<SEC-DOCUMENT>0000950103-25-013576.txt : 20251023
<SEC-HEADER>0000950103-25-013576.hdr.sgml : 20251023
<ACCEPTANCE-DATETIME>20251023160839
ACCESSION NUMBER:		0000950103-25-013576
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20251023
DATE AS OF CHANGE:		20251023

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251413113

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251413114

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>dp236266_424b3-us2522658.htm
<DESCRIPTION>AMENDED AND RESTATED PRELIMINARY PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>This Amended and Restated Pricing Supplement
No. 2025-USNCH29030 is being filed to revise the contingent coupon rate.</B></P>

<P STYLE="color: red; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">The information in this preliminary
pricing supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities
and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, underlying supplement, prospectus
supplement and prospectus are not an offer to sell these securities, nor are they soliciting an offer to buy these securities, in any
state where the offer or sale is not permitted.</P>

<P STYLE="color: red; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">SUBJECT TO COMPLETION, DATED OCTOBER
23, 2025</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 53%; font-size: 10pt; color: #888888"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 47%">
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">October&nbsp;&nbsp;&nbsp;&nbsp;
    , 2025</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Medium-Term Senior Notes, Series
    N</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Amended and Restated Pricing Supplement
    No. 2025-USNCH29030</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Filed Pursuant to Rule 424(b)(3)</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Registration Statement Nos. 333-270327
    and 333-270327-01</P></TD></TR>
  </TABLE>
<P STYLE="color: #59AE43; font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Callable Contingent Coupon Equity Linked Securities
Linked to the Worst Performing of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP>
Index Due May 2, 2030</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>The securities offered by this pricing supplement are unsecured debt securities issued by Citigroup Global Markets Holdings Inc. and
guaranteed by Citigroup Inc. The securities offer the potential for periodic contingent coupon payments at an annualized rate that, if
all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities of the same maturity.
In exchange for this higher potential yield, you must be willing to accept the risks that (i) your actual yield may be lower than the
yield on our conventional debt securities of the same maturity because you may not receive one or more, or any, contingent coupon payments,
and (ii) the value of what you receive at maturity may be significantly less than the stated principal amount of your securities, and
may be zero. Each of these risks will depend solely on the performance of the <B>worst performing</B> of the underlyings specified below.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>We have the right to call the securities for mandatory redemption on any potential redemption date specified below.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>You will be subject to risks associated with <U>each</U> of the underlyings and will be negatively affected by adverse movements in
<U>any one</U> of the underlyings. Although you will have downside exposure to the worst performing underlying, you will not receive dividends
with respect to any underlying or participate in any appreciation of any underlying.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>Investors in the securities must be willing to accept (i) an investment that may have limited or no liquidity and (ii) the risk of
not receiving any payments due under the securities if we and Citigroup Inc. default on our obligations. <B>All payments on the securities
are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B></TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="color: white"><B>KEY TERMS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issuer:</B></FONT></TD>
    <TD STYLE="width: 80%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Guarantee:</B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 20%; border-right: #59AE43 1pt solid"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlyings:</B></FONT></TD>
    <TD STYLE="width: 21%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Initial underlying value</B></FONT><B><FONT STYLE="color: #59AE43"><SUP>*</SUP></FONT></B></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Coupon barrier value</B></FONT><B><FONT STYLE="color: #59AE43"><SUP>**</SUP></FONT></B></TD>
    <TD STYLE="width: 19%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Final barrier value</B></FONT><B><FONT STYLE="color: #59AE43"><SUP>***</SUP></FONT></B></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">iShares<SUP>&reg;</SUP> MSCI EAFE ETF</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$</FONT>&#9;</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$</FONT>&#9;</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$</FONT>&#9;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Russell 2000<SUP>&reg;</SUP> Index</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">&#9;</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">&#9;</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">&#9;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">S&amp;P 500<SUP>&reg;</SUP> Index</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">&#9;</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">&#9;</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">&#9;</TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 80%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>*</SUP>For each underlying, its closing value on the pricing date</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>**</SUP>For each underlying, 80.00% of its initial underlying value</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>***</SUP>For each underlying, 60.00% of its initial underlying
    value</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Stated principal amount:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,000 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Pricing date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">October 28, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">October 31, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Valuation date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">April 29, 2030, subject to postponement if such date is not a scheduled trading day or certain market disruption events occur</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Maturity date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Unless earlier redeemed, May 2, 2030</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Contingent coupon payment dates:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For each observation period, the fifth business day after the observation period end-date for such observation period, except that the contingent coupon payment date following the final observation period will be the maturity date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Contingent coupon:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">On each contingent coupon payment date, unless previously redeemed, the securities will pay a contingent coupon equal to at least 2.725% of the stated principal amount of the securities (equivalent to a contingent coupon rate of at least 10.90% per annum) (to be determined on the pricing date) <B>if and only if</B> a coupon barrier event has not occurred during the related observation period. <B>If a coupon barrier event occurs during an observation period, you will not receive any contingent coupon payment on the related contingent coupon payment date. A coupon barrier event will occur if the closing value of any underlying is less than its coupon barrier value on any trading day for that underlying during an observation period.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Payment at maturity:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the securities are not redeemed prior to maturity, you will receive
    at maturity for each security you then hold (in addition to the final contingent coupon payment, if applicable):</P>
    <P STYLE="font: 10pt Wingdings; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt">&sect;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 0pt 0pt 0.4in; text-indent: 0in">If the final underlying value of the worst
    performing underlying is <B>greater than or equal to</B> its final barrier value: $1,000</P>
    <P STYLE="font: 10pt Wingdings; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt">&sect;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 0pt 0pt 0.4in; text-indent: 0in">If the final underlying value of the worst
    performing underlying is <B>less than</B> its final barrier value:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in">$1,000 + ($1,000 &times; the underlying return of the worst
    performing underlying)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the securities are not redeemed prior to maturity and the final
    underlying value of the worst performing underlying is less than its final barrier value, you will receive significantly less than the
    stated principal amount of your securities, and possibly nothing, at maturity, and you will not receive any contingent coupon payment
    at maturity.</B></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Listing:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The securities will not be listed on any securities exchange</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriter:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Citigroup Global Markets Inc. (&ldquo;<B>CGMI</B>&rdquo;), an affiliate of the issuer, acting as principal</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee and issue price:</B></FONT></TD>
    <TD STYLE="width: 26%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="width: 28%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="width: 26%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Proceeds to issuer<SUP>(3)</SUP></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Per security:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$20.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$980.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Total:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><I>(Key Terms continued on next page)</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(1) Citigroup Global Markets Holdings Inc. currently expects that the
estimated value of the securities on the pricing date will be at least $909.50 per security, which will be less than the issue price.
The estimated value of the securities is based on CGMI&rsquo;s proprietary pricing models and our internal funding rate. It is not an
indication of actual profit to CGMI or other of our affiliates, nor is it an indication of the price, if any, at which CGMI or any other
person may be willing to buy the securities from you at any time after issuance. See &ldquo;Valuation of the Securities&rdquo; in this
pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(2) CGMI will receive an underwriting fee of up to $20.00 for each security
sold in this offering. The total underwriting fee and proceeds to issuer in the table above give effect to the actual total underwriting
fee. For more information on the distribution of the securities, see &ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement.
In addition to the underwriting fee, CGMI and its affiliates may profit from expected hedging activity related to this offering, even
if the value of the securities declines. See &ldquo;Use of Proceeds and Hedging&rdquo; in the accompanying prospectus.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(3) The per security proceeds to issuer indicated above represent the
minimum per security proceeds to issuer for any security, assuming the maximum per security underwriting fee. As noted above, the underwriting
fee is variable.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the securities involves risks not associated with an
investment in conventional debt securities. See &ldquo;Summary Risk Factors&rdquo; beginning on page PS-6.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of the securities or determined that this pricing supplement and the accompanying
product supplement, underlying supplement, prospectus supplement and prospectus are truthful or complete. Any representation to the contrary
is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>You should read this pricing supplement together
with the accompanying product supplement, underlying supplement, prospectus supplement and prospectus, which can be accessed via the hyperlinks
below:</I></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003814/dp190219_424b2-coba0410.htm" STYLE="color: rgb(89,174,67); text-decoration: underline"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Product Supplement No. EA-04-10 dated March 7, 2023</B></FONT></A></TD>
    <TD STYLE="width: 50%; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm" STYLE="color: rgb(89,174,67); text-decoration: underline"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying Supplement No. 11 dated March 7, 2023</B></FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE43"><B><A HREF="https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm" STYLE="color: rgb(89,174,67); text-decoration: underline">Prospectus Supplement and Prospectus each dated March 7, 2023</A></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The securities are not bank deposits and are
not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of,
or guaranteed by, a bank.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD COLSPAN="2"><FONT STYLE="color: white"><B>KEY TERMS (continued)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 23%"><FONT STYLE="font-size: 10pt; color: rgb(89,174,67)"><B>Coupon barrier event:</B></FONT></TD>
    <TD STYLE="width: 77%"><FONT STYLE="font-size: 10pt">A coupon barrier event will occur with respect to an observation period if the closing value of any underlying is less than its coupon barrier value on any trading day for that underlying during that observation period.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Observation periods:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Each observation period will consist of each day from but excluding an observation period end-date to and including the following observation period end-date, provided that the first observation period will consist of each day from but excluding the pricing date to and including the first observation period end-date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Observation period end-dates:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">January 28, 2026, April 28, 2026, July 28, 2026, October 28, 2026, January 28, 2027, April 28, 2027, July 28, 2027, October 28, 2027, January 28, 2028, April 28, 2028, July 28, 2028, October 30, 2028, January 29, 2029, April 30, 2029, July 30, 2029, October 29, 2029, January 28, 2030 and April 29, 2030</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Trading day:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For any underlying, a scheduled trading day for that underlying on which a market disruption event has not occurred with respect to that underlying.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Redemption:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">We may call the securities, in whole and not in part, for mandatory redemption on any potential redemption date upon not less than five business days&rsquo; notice. Following an exercise of our call right, you will receive for each security you then hold an amount in cash equal to $1,000 plus the related contingent coupon payment, if any.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Potential redemption dates:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The contingent coupon payment dates related to the observation period end-dates scheduled to occur on April 28, 2026, July 28, 2026, October 28, 2026, January 28, 2027, April 28, 2027, July 28, 2027, October 28, 2027, January 28, 2028, April 28, 2028, July 28, 2028, October 30, 2028, January 29, 2029, April 30, 2029, July 30, 2029, October 29, 2029 and January 28, 2030</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Final underlying value:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For each underlying, its closing value on the valuation date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Worst performing underlying:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The underlying with the lowest underlying return</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying return:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For each underlying, (i) its final underlying value <I>minus</I> its initial underlying value, <I>divided by</I> (ii) its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">17331BPR4 / US17331BPR41</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Additional Information</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>General.</B> The terms of the securities are set forth in the accompanying
product supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement. The accompanying product supplement,
prospectus supplement and prospectus contain important disclosures that are not repeated in this pricing supplement. For example, the
accompanying product supplement contains important information about how the closing value of each underlying will be determined and about
adjustments that may be made to the terms of the securities upon the occurrence of market disruption events and other specified events
with respect to each underlying. The accompanying underlying supplement contains information about each underlying that is not repeated
in this pricing supplement. It is important that you read the accompanying product supplement, underlying supplement, prospectus supplement
and prospectus together with this pricing supplement before deciding whether to invest in the securities. Certain terms used but not defined
in this pricing supplement are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Closing Value.</B> The &ldquo;closing value&rdquo; of an underlying
on any date is (i) in the case of an underlying that is an underlying index, its closing level on such date and (ii) in the case of an
underlying that is an underlying ETF, the closing price of its underlying shares on such date, as provided in the accompanying product
supplement. The &ldquo;underlying shares&rdquo; of an underlying ETF are its shares that are traded on a U.S. national securities exchange.
Please see the accompanying product supplement for more information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Hypothetical Examples</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples in the first section below illustrate how to determine
whether a contingent coupon will be paid with respect to an observation period. The examples in the second section below illustrate how
to determine the payment at maturity on the securities, assuming the securities are not redeemed prior to maturity. The examples are solely
for illustrative purposes, do not show all possible outcomes and are not a prediction of any payment that may be made on the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are based on the following hypothetical values and
do not reflect the actual initial underlying values, coupon barrier values or final barrier values of the underlyings. For the actual
initial underlying value, coupon barrier value and final barrier value of each underlying, see the cover page of this pricing supplement.
We have used these hypothetical values, rather than the actual values, to simplify the calculations and aid understanding of how the securities
work. However, you should understand that the actual payments on the securities will be calculated based on the actual initial underlying
value, coupon barrier value and final barrier value of each underlying, and not the hypothetical values indicated below. For ease of analysis,
figures below have been rounded. The examples below assume that the contingent coupon rate is set at the lowest value indicated on the
cover page of this pricing supplement. The actual contingent coupon rate will be determined on the pricing date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 25%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical initial underlying value</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical coupon barrier value</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical final barrier value</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">iShares<SUP>&reg;</SUP> MSCI EAFE ETF</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$100.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$80.00 (80.00% of its hypothetical initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$60.00 (60.00% of its hypothetical initial underlying value)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Russell 2000<SUP>&reg;</SUP> Index</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">100.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">80.00 (80.00% of its hypothetical initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">60.00 (60.00% of its hypothetical initial underlying value)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">S&amp;P 500<SUP>&reg;</SUP> Index</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">100.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">80.00 (80.00% of its hypothetical initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">60.00 (60.00% of its hypothetical initial underlying value)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><B><I>Hypothetical Examples of Contingent Coupon Payments
with Respect to an Observation Period</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The three hypothetical examples below illustrate how to determine whether
a contingent coupon will be paid with respect to an observation period, assuming that the lowest closing values of the underlyings on
any trading day during an observation period are as indicated below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 20%; border: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical lowest closing value of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF on any trading day during an observation period</B></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical lowest closing value of the Russell 2000<SUP>&reg;</SUP> Index on any trading day during an observation period</B></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical lowest closing value of the S&amp;P 500<SUP>&reg;</SUP> Index on any trading day during an observation period</B></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical payment per $1,000.00 security on related contingent coupon payment date</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 1</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$120<BR>
(<B>greater than</B> coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">85<BR>
(<B>greater than</B> coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">115<BR>
(<B>greater than</B> coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$27.25</B><BR>
(contingent coupon is paid)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 2</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$45<BR>
(<B>less than</B> coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">120<BR>
(<B>greater than</B> coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">140<BR>
(<B>greater than</B> coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$0.00</B><BR>
(no contingent coupon)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 3</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$20<BR>
(<B>less than</B> coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">40<BR>
(<B>less than</B> coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">10<BR>
(<B>less than</B> coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$0.00</B><BR>
(no contingent coupon)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 1:</B></FONT> In this example,
the closing value of each underlying is greater than its coupon barrier value on each trading day during an observation period. In this
scenario, a coupon barrier event does not occur and investors in the securities would receive the contingent coupon payment on the related
contingent coupon payment date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 2:</B></FONT> In this example,
the closing value of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF is less than its coupon barrier value on at least one trading day during
an observation period. As a result, investors would not receive any payment on the related contingent coupon payment date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investors in the securities will not receive a contingent coupon
with respect to an observation period if the closing value of any underlying is less than its coupon barrier value on any trading day
for that underlying during that observation period, even if only one underlying experiences a coupon barrier event and even if the closing
value of that underlying is greater than its coupon barrier value on each other trading day during that observation period.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 3:</B></FONT> In this example,
the closing value of each underlying is less than its coupon barrier value on at least one trading day during an observation period. In
this scenario, investors would not receive any payment on the related contingent coupon payment date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><B><I>Hypothetical Examples of the Payment at Maturity
on the Securities</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The next three hypothetical examples illustrate the calculation of the
payment at maturity on the securities, assuming that the securities have not been earlier redeemed and that the final underlying values
of the underlyings are as indicated below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 20%; border: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical final underlying value of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF</B></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical final underlying value of the Russell 2000<SUP>&reg;</SUP> Index</B></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical final underlying value of the S&amp;P 500<SUP>&reg;</SUP> Index</B></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical payment at maturity per $1,000.00 security</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 4</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$110<BR>
(underlying return =<BR>
($110 - $100) / $100 = 10%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">120<BR>
(underlying return =<BR>
(120 - 100) / 100 = 20%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">130<BR>
(underlying return =<BR>
(130 - 100) / 100 = 30%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$1,000.00, plus the contingent coupon payment, if any</B><BR>
(contingent coupon is paid)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 5</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$110<BR>
(underlying return =<BR>
($110 - $100) / $100 = 10%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">120<BR>
(underlying return =<BR>
(120 - 100) / 100 = 20%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">50<BR>
(underlying return =<BR>
(50 - 100) / 100 = -50%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$500.00</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 6</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$20<BR>
(underlying return =<BR>
($20 - $100) / $100 = -80%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">55<BR>
(underlying return =<BR>
(55 - 100) / 100 = -45%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">65<BR>
(underlying return =<BR>
(65 - 100) / 100 = -35%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$200.00</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 4:</B></FONT> On the valuation
date, the iShares<SUP>&reg;</SUP> MSCI EAFE ETF has the lowest underlying return and, therefore, is the worst performing underlying. In
this scenario, the final underlying value of the worst performing underlying is greater than its final barrier value. Accordingly, at
maturity, you would receive the stated principal amount of the securities <I>plus</I> the contingent coupon payment, if any, due at maturity,
but you would not participate in the appreciation of any of the underlyings.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 5:</B></FONT> On the valuation
date, the S&amp;P 500<SUP>&reg;</SUP> Index has the lowest underlying return and, therefore, is the worst performing underlying. In this
scenario, the final underlying value of the worst performing underlying is less than its final barrier value. Accordingly, at maturity,
you would receive a payment per security calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity = $1,000.00 + ($1,000.00 &times; the underlying
return of the worst performing underlying)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000.00 + ($1,000.00 &times; -50.00%)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000.00 + -$500.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $500.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, because the final underlying value of the worst performing
underlying is less than its final barrier value, you would lose a significant portion of your investment in the securities. In addition,
because the final underlying value of the worst performing underlying is below its coupon barrier value, a coupon barrier event has necessarily
occurred and you would not receive any contingent coupon payment at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 6:</B></FONT> On the valuation
date, the iShares<SUP>&reg;</SUP> MSCI EAFE ETF has the lowest underlying return and, therefore, is the worst performing underlying. In
this scenario, the final underlying value of the worst performing underlying is less than its final barrier value. Accordingly, at maturity,
you would receive a payment per security calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity = $1,000.00 + ($1,000.00 &times; the underlying
return of the worst performing underlying)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000.00 + ($1,000.00 &times; -80.00%)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000.00 + -$800.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $200.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, because the final underlying value of the worst performing
underlying is less than its final barrier value, you would lose a significant portion of your investment in the securities. In addition,
because the final underlying value of the worst performing underlying is below its coupon barrier value, a coupon barrier event has necessarily
occurred and you would not receive any contingent coupon payment at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>It is possible that the closing value of at least one underlying
will be less than its coupon barrier value on at least one trading day for that underlying during each observation period and that the
final underlying value of the worst performing underlying will be less than its final barrier value, such that you will not receive any
contingent coupon payments over the term of the securities and will receive significantly less than the stated principal amount of your
securities, and possibly nothing, at maturity.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Summary Risk Factors</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the securities is significantly riskier than an investment
in conventional debt securities. The securities are subject to all of the risks associated with an investment in our conventional debt
securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the securities,
and are also subject to risks associated with each underlying. Accordingly, the securities are suitable only for investors who are capable
of understanding the complexities and risks of the securities. You should consult your own financial, tax and legal advisors as to the
risks of an investment in the securities and the suitability of the securities in light of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the securities. You should read this summary together with the more detailed description of risks relating to an investment in the
securities contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying product
supplement. You should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents incorporated
by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and any subsequent
Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You may lose a significant portion or all of your investment.</B> Unlike conventional debt securities, the securities do not provide
for the repayment of the stated principal amount at maturity in all circumstances. If the securities are not redeemed prior to maturity,
your payment at maturity will depend on the final underlying value of the worst performing underlying. If the final underlying value of
the worst performing underlying is less than its final barrier value, you will lose 1% of the stated principal amount of your securities
for every 1% by which the worst performing underlying has declined from its initial underlying value. There is no minimum payment at maturity
on the securities, and you may lose up to all of your investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will not receive any contingent coupon for any observation period during which a coupon barrier event occurs.</B> A contingent
coupon payment will be made on a contingent coupon payment date if and only if a coupon barrier event does not occur during the related
observation period. A coupon barrier event will occur with respect to an observation period if the closing value of any underlying is
less than its coupon barrier value on any trading day for that underlying during that observation period. If a coupon barrier event occurs
during any observation period, you will not receive any contingent coupon payment on the related contingent coupon payment date. If a
coupon barrier event occurs during each of the observation periods, you will not receive any contingent coupon payments over the term
of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The contingent coupon payments are contingent on the closing value of each underlying on each trading day throughout the observation
periods.</B> Whether the contingent coupon payment will be made with respect to an observation period will be based on the closing value
of each underlying on each trading day during that observation period. If the closing value of any underlying is less than its coupon
barrier value on any trading day during an observation period, you will not receive a contingent coupon payment on the related contingent
coupon payment date, even if only one underlying experiences a coupon barrier event and even if the closing value of that underlying is
greater than its coupon barrier value on each other trading day during that observation period. As a result, the potential to receive
a contingent coupon payment with respect to an observation period can be knocked out by a temporary event that affects only one underlying
on only one day during that observation period.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Higher contingent coupon rates are associated with greater risk.</B> The securities offer contingent coupon payments at an annualized
rate that, if all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities of the same
maturity. This higher potential yield is associated with greater levels of expected risk as of the pricing date for the securities, including
the risk that you may not receive a contingent coupon payment on one or more, or any, contingent coupon payment dates and the risk that
the value of what you receive at maturity may be significantly less than the stated principal amount of your securities and may be zero.
The volatility of, and correlation between, the closing values of the underlyings are important factors affecting these risks. Greater
expected volatility of, and lower expected correlation between, the closing values of the underlyings as of the pricing date may result
in a higher contingent coupon rate, but would also represent a greater expected likelihood as of the pricing date that a coupon barrier
event will occur during one or more observation periods, such that you will not receive one or more, or any, contingent coupon payments
during the term of the securities and that the final underlying value of the worst performing underlying will be less than its final barrier
value, such that you will not be repaid the stated principal amount of your securities at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to heightened risk because they have multiple underlyings.</B> The securities are more risky than similar
investments that may be available with only one underlying. With multiple underlyings, there is a greater chance that any one underlying
will perform poorly, adversely affecting your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to the risks of each of the underlyings and will be negatively affected if any one underlying performs
poorly.</B> You are subject to risks associated with each of the underlyings. If any one underlying performs poorly, you will be negatively
affected. The securities are not linked to a basket composed of the underlyings, where the blended performance of the underlyings would
be better than the performance of the worst performing of the underlyings alone. Instead, you are subject to the full risks of whichever
of the underlyings is the worst performing of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will not benefit in any way from the performance of any better performing underlying.</B> The return on the securities depends
solely on the performance of the worst performing of the underlyings, and you will not benefit in any way from the performance of any
better performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will be subject to risks relating to the relationship between the underlyings.</B> It is preferable from your perspective for
the underlyings to be correlated with each other, in the sense that their closing values tend to increase or decrease at similar times
and by similar magnitudes. By investing in the securities, you assume the risk that the underlyings will not exhibit this relationship.
The less correlated the underlyings, the more likely it is that any one of the underlyings will perform poorly over the term of the securities.
All that is necessary for the securities to perform poorly is for one of the underlyings to perform poorly. It is impossible to predict
what the</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">relationship between the underlyings will
be over the term of the securities. The underlyings differ in significant ways and, therefore, may not be correlated with each other.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You may not be adequately compensated for assuming the downside risk of the worst performing underlying.</B> The potential contingent
coupon payments on the securities are the compensation you receive for assuming the downside risk of the worst performing underlying,
as well as all the other risks of the securities. That compensation is effectively &ldquo;at risk&rdquo; and may, therefore, be less than
you currently anticipate. First, the actual yield you realize on the securities could be lower than you anticipate because the coupon
is &ldquo;contingent&rdquo; and you may not receive a contingent coupon payment on one or more, or any, of the contingent coupon payment
dates. Second, the contingent coupon payments are the compensation you receive not only for the downside risk of the worst performing
underlying, but also for all of the other risks of the securities, including the risk that the securities may be redeemed prior to maturity,
interest rate risk and our and Citigroup Inc.&rsquo;s credit risk. If those other risks increase or are otherwise greater than you currently
anticipate, the contingent coupon payments may turn out to be inadequate to compensate you for all the risks of the securities, including
the downside risk of the worst performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>We may redeem the securities at our option, which will limit your ability to receive the contingent coupon payments.</B> We may
redeem the securities on any potential redemption date. In the event that we redeem the securities, you will receive the stated principal
amount of your securities and the related contingent coupon payment, if any. Thus, the term of the securities may be limited. If we redeem
the securities prior to maturity, you will not receive any additional contingent coupon payments. Moreover, you may not be able to reinvest
your funds in another investment that provides a similar yield with a similar level of risk. If we redeem the securities prior to maturity,
it is likely to be at a time when the underlyings are performing in a manner that would otherwise have been favorable to you. By contrast,
if the underlyings are performing unfavorably from your perspective, we are less likely to redeem the securities. If we redeem the securities,
we will do so at a time that is advantageous to us and without regard to your interests.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities offer downside exposure to the worst performing underlying, but no upside exposure to any underlying.</B> You will
not participate in any appreciation in the value of any underlying over the term of the securities. Consequently, your return on the securities
will be limited to the contingent coupon payments you receive, if any, and may be significantly less than the return on any underlying
over the term of the securities. In addition, as an investor in the securities, you will not receive any dividends or other distributions
or have any other rights with respect to any of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The payment at maturity depends on the closing value of the worst performing underlying on a single day.</B> If the closing value
of the worst performing underlying on the valuation date is less than its final barrier value, you will not receive the full stated principal
amount of your securities at maturity, even if the closing value of the worst performing underlying is greater than its final barrier
value on other dates during the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B> If we default on
our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you
under the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.</B> The securities
will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. CGMI currently
intends to make a secondary market in relation to the securities and to provide an indicative bid price for the securities on a daily
basis. Any indicative bid price for the securities provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the securities can be sold at that
price, or at all. CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and for
any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the securities because it is likely
that CGMI will be the only broker-dealer that is willing to buy your securities prior to maturity. Accordingly, an investor must be prepared
to hold the securities until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities on the pricing date, based on CGMI&rsquo;s proprietary pricing models and our internal funding
rate, will be less than the issue price.</B> The difference is attributable to certain costs associated with selling, structuring and
hedging the securities that are included in the issue price. These costs include (i) any selling concessions or other fees paid in connection
with the offering of the securities, (ii) hedging and other costs incurred by us and our affiliates in connection with the offering of
the securities and (iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates in connection
with hedging our obligations under the securities. These costs adversely affect the economic terms of the securities because, if they
were lower, the economic terms of the securities would be more favorable to you. The economic terms of the securities are also likely
to be adversely affected by the use of our internal funding rate, rather than our secondary market rate, to price the securities. See
&ldquo;The estimated value of the securities would be lower if it were calculated based on our secondary market rate&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities was determined for us by our affiliate using proprietary pricing models.</B> CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have
made discretionary judgments about the inputs to its models, such as the volatility of, and correlation between, the closing values of
the underlyings, dividend yields on the underlyings and interest rates. CGMI&rsquo;s views on these inputs may differ from your or others&rsquo;
views, and as an underwriter in this offering, CGMI&rsquo;s interests may conflict with yours. Both the models and the inputs to the models
may prove to be wrong and therefore not an accurate reflection of the value of the securities. Moreover, the estimated value of the securities
set forth on the cover page of this pricing supplement may differ from the value that we or our affiliates may determine for the securities
for other purposes, including for accounting purposes. You should not invest in the securities because of the estimated value of the securities.
Instead, you should be willing to hold the securities to maturity irrespective of the initial estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities would be lower if it were calculated based on our secondary market rate.</B> The estimated
value of the securities included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which
we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally lower than our secondary
market</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">rate, which is the rate that CGMI will use
in determining the value of the securities for purposes of any purchases of the securities from you in the secondary market. If the estimated
value included in this pricing supplement were based on our secondary market rate, rather than our internal funding rate, it would likely
be lower. We determine our internal funding rate based on factors such as the costs associated with the securities, which are generally
higher than the costs associated with conventional debt securities, and our liquidity needs and preferences. Our internal funding rate
is not an interest rate that is payable on the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Because there is not an active market for traded instruments
referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of traded instruments
referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the securities, but subject
to adjustments that CGMI makes in its sole discretion. As a result, our secondary market rate is not a market-determined measure of our
creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted for discretionary
factors such as CGMI&rsquo;s preferences with respect to purchasing the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities is not an indication of the price, if any, at which CGMI or any other person may be willing
to buy the securities from you in the secondary market.</B> Any such secondary market price will fluctuate over the term of the securities
based on the market and other factors described in the next risk factor. Moreover, unlike the estimated value included in this pricing
supplement, any value of the securities determined for purposes of a secondary market transaction will be based on our secondary market
rate, which will likely result in a lower value for the securities than if our internal funding rate were used. In addition, any secondary
market price for the securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount
of the securities to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions.
As a result, it is likely that any secondary market price for the securities will be less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The value of the securities prior to maturity will fluctuate based on many unpredictable factors.</B> The value of your securities
prior to maturity will fluctuate based on the closing values of the underlyings, the volatility of, and correlation between, the closing
values of the underlyings, dividend yields on the underlyings, interest rates generally, the time remaining to maturity and our and Citigroup
Inc.&rsquo;s creditworthiness, as reflected in our secondary market rate, among other factors described under &ldquo;Risk Factors Relating
to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The value of your securities prior to maturity will fluctuate based
on many unpredictable factors&rdquo; in the accompanying product supplement. Changes in the closing values of the underlyings may not
result in a comparable change in the value of your securities. You should understand that the value of your securities at any time prior
to maturity may be significantly less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment.</B> The amount of this temporary upward
adjustment will steadily decline to zero over the temporary adjustment period. See &ldquo;Valuation of the Securities&rdquo; in this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The iShares<SUP>&reg;</SUP> MSCI EAFE ETF is subject to risks associated with non-U.S. markets.</B> Investments linked to the value
of non-U.S. stocks involve risks associated with the securities markets in those countries, including risks of volatility in those markets,
governmental intervention in those markets and cross-shareholdings in companies in certain countries. Also, there is generally less publicly
available information about companies in some of these jurisdictions than about U.S. companies that are subject to the reporting requirements
of the SEC. Further, non-U.S. companies are generally subject to accounting, auditing and financial reporting standards and requirements
and securities trading rules that are different from those applicable to U.S. reporting companies. The prices of securities in foreign
markets may be affected by political, economic, financial and social factors in those countries, or global regions, including changes
in government, economic and fiscal policies and currency exchange laws. Moreover, the economies in such countries may differ favorably
or unfavorably from the economy of the United States in such respects as growth of gross national product, rate of inflation, capital
reinvestment, resources and self-sufficiency. In addition, the iShares<SUP>&reg;</SUP> MSCI EAFE ETF may include companies in countries
with emerging markets. Countries with emerging markets may have relatively unstable governments, may present the risks of nationalization
of businesses, restrictions on foreign ownership and prohibitions on the repatriation of assets, and may have less protection of property
rights than more developed countries. The economies of countries with emerging markets may be based on only a few industries, may be highly
vulnerable to changes in local or global trade conditions (due to economic dependence upon commodity prices and international trade),
and may suffer from extreme and volatile debt burdens, currency devaluations or inflation rates. Local securities markets may trade a
small number of securities and may be unable to respond effectively to increases in trading volume, potentially making prompt liquidation
of holdings difficult or impossible at times.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Fluctuations in exchange rates will affect the closing value of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF.</B> Because the iShares<SUP>&reg;</SUP>
MSCI EAFE ETF includes stocks that trade outside the United States and the closing value of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF
is based on the U.S. dollar value of those stocks, the iShares<SUP>&reg;</SUP> MSCI EAFE ETF is subject to currency exchange rate risk
with respect to each of the currencies in which such stocks trade. Exchange rate movements may be volatile and may be driven by numerous
factors specific to the relevant countries, including the supply of, and the demand for, the applicable currencies, as well as government
policy and intervention and macroeconomic factors. Exchange rate movements may also be influenced significantly by speculative trading.
In general, if the U.S. dollar strengthens against the currencies in which the stocks included in the iShares<SUP>&reg;</SUP> MSCI EAFE
ETF trade, the closing value of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF will be adversely affected for that reason alone.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The Russell 2000<SUP>&reg;</SUP> Index is subject to risks associated with small capitalization stocks.</B> The stocks that constitute
the Russell 2000<SUP>&reg;</SUP> Index are issued by companies with relatively small market capitalization. The stock prices of smaller
companies may be more volatile than stock prices of large capitalization companies. These companies tend to be less well-established than
large market capitalization companies. Small capitalization companies may be less able to withstand adverse economic, market, trade and
competitive conditions relative to larger companies. Small capitalization companies are less likely to pay dividends on their stocks,
and the presence of a dividend payment could be a factor that limits downward stock price pressure under adverse market conditions.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Our offering of the securities is not a recommendation of any underlying.</B> The fact that we are offering the securities does
not mean that we believe that investing in an instrument linked to the underlyings is likely to achieve favorable returns. In fact, as
we are part of a global financial institution, our affiliates may have positions (including short positions) in the underlyings or in
instruments related to the underlyings, and may publish research or express opinions, that in each case are inconsistent with an investment
linked to the underlyings. These and other activities of our affiliates may affect the closing values of the underlyings in a way that
negatively affects the value of and your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The closing value of an underlying may be adversely affected by our or our affiliates&rsquo; hedging and other trading activities.</B>
We expect to hedge our obligations under the securities through CGMI or other of our affiliates, who may take positions in the underlyings
or in financial instruments related to the underlyings and may adjust such positions during the term of the securities. Our affiliates
also take positions in the underlyings or in financial instruments related to the underlyings on a regular basis (taking long or short
positions or both), for their accounts, for other accounts under their management or to facilitate transactions on behalf of customers.
These activities could affect the closing values of the underlyings in a way that negatively affects the value of and your return on the
securities. They could also result in substantial returns for us or our affiliates while the value of the securities declines.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>We and our affiliates may have economic interests that are adverse to yours as a result of our affiliates&rsquo; business activities.</B>
Our affiliates engage in business activities with a wide range of companies. These activities include extending loans, making and facilitating
investments, underwriting securities offerings and providing advisory services. These activities could involve or affect the underlyings
in a way that negatively affects the value of and your return on the securities. They could also result in substantial returns for us
or our affiliates while the value of the securities declines. In addition, in the course of this business, we or our affiliates may acquire
non-public information, which will not be disclosed to you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities.</B> If
certain events occur during the term of the securities, such as market disruption events and other events with respect to an underlying,
CGMI, as calculation agent, will be required to make discretionary judgments that could significantly affect your return on the securities.
In making these judgments, the calculation agent&rsquo;s interests as an affiliate of ours could be adverse to your interests as a holder
of the securities. See &ldquo;Risk Factors Relating to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The calculation
agent, which is an affiliate of ours, will make important determinations with respect to the securities&rdquo; in the accompanying product
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>In the case of an underlying that is an underlying ETF, even if the underlying pays a dividend that it identifies as special or
extraordinary, no adjustment will be required under the securities for that dividend unless it meets the criteria specified in the accompanying
product supplement.</B> In general, an adjustment will not be made under the terms of the securities for any cash dividend paid by the
underlying unless the amount of the dividend per share, together with any other dividends paid in the same quarter, exceeds the dividend
paid per share in the most recent quarter by an amount equal to at least 10% of the closing value of that underlying on the date of declaration
of the dividend. Any dividend will reduce the closing value of the underlying by the amount of the dividend per share. If the underlying
pays any dividend for which an adjustment is not made under the terms of the securities, holders of the securities will be adversely affected.
See &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying Company or an Underlying
ETF&mdash;Dilution and Reorganization Adjustments&mdash;Certain Extraordinary Cash Dividends&rdquo; in the accompanying product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>In the case of an underlying that is an underlying ETF, the securities will not be adjusted for all events that may have a dilutive
effect on or otherwise adversely affect the closing value of the underlying.</B> For example, we will not make any adjustment for ordinary
dividends or extraordinary dividends that do not meet the criteria described above, partial tender offers or additional underlying share
issuances. Moreover, the adjustments we do make may not fully offset the dilutive or adverse effect of the particular event. Investors
in the securities may be adversely affected by such an event in a circumstance in which a direct holder of the underlying shares of the
underlying would not.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>In the case of an underlying that is an underlying ETF, the securities may become linked to an underlying other than the original
underlying upon the occurrence of a reorganization event or upon the delisting of the underlying shares of that original underlying.</B>
For example, if the underlying enters into a merger agreement that provides for holders of its underlying shares to receive shares of
another entity and such shares are marketable securities, the closing value of that underlying following consummation of the merger will
be based on the value of such other shares. Additionally, if the underlying shares of the underlying are delisted, the calculation agent
may select a successor underlying. See &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities Linked to an
Underlying Company or an Underlying ETF&rdquo; in the accompanying product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>In the case of the underlying that is an underlying ETF, the value and performance of the underlying shares of the underlying may
not completely track the performance of the underlying index that the underlying seeks to track or the net asset value per share of the
underlying.</B> In the case of the underlying that is an underlying ETF, the underlying does not fully replicate the underlying index
that it seeks to track and may hold securities different from those included in its underlying index. In addition, the performance of
the underlying will reflect additional transaction costs and fees that are not included in the calculation of its underlying index. All
of these factors may lead to a lack of correlation between the performance of the underlying and its underlying index. In addition, corporate
actions with respect to the equity securities held by the underlying (such as mergers and spin-offs) may impact the variance between the
performance of the underlying and its underlying index. Finally, because the underlying shares are traded on an exchange and are subject
to market supply and investor demand, the closing value of the underlying may differ from the net asset value per share of the underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">During periods of market volatility, securities included in
the underlying&rsquo;s underlying index may be unavailable in the secondary market, market participants may be unable to calculate accurately
the net asset value per share of the underlying and the liquidity of the underlying may be adversely affected. This kind of market volatility
may also disrupt the ability of market participants to create and redeem shares of the underlying. Further, market volatility may adversely
affect, sometimes materially, the price at which market</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">participants are willing to buy and sell the underlying shares.
As a result, under these circumstances, the closing value of the underlying may vary substantially from the net asset value per share
of the underlying. For all of the foregoing reasons, the performance of the underlying may not correlate with the performance of its underlying
index and/or its net asset value per share, which could materially and adversely affect the value of the securities and/or reduce your
return on the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Changes that affect the underlyings may affect the value of your securities.</B> The sponsors of the underlyings may at any time
make methodological changes or other changes in the manner in which they operate that could affect the values of the underlyings. We are
not affiliated with any such underlying sponsor and, accordingly, we have no control over any changes any such sponsor may make. Such
changes could adversely affect the performance of the underlyings and the value of and your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The U.S. federal tax consequences of an investment in the securities are unclear.</B> There is no direct legal authority regarding
the proper U.S. federal tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the
&ldquo;IRS&rdquo;). Consequently, significant aspects of the tax treatment of the securities are uncertain, and the IRS or a court might
not agree with the treatment of the securities as described in &ldquo;United States Federal Tax Considerations&rdquo; below. If the IRS
were successful in asserting an alternative treatment of the securities, the tax consequences of the ownership and disposition of the
securities might be materially and adversely affected. Moreover, future legislation, Treasury regulations or IRS guidance could adversely
affect the U.S. federal tax treatment of the securities, possibly retroactively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Non-U.S. investors should note that persons having withholding
responsibility in respect of the securities may withhold on any coupon payment paid to a non-U.S. investor, generally at a rate of 30%.
To the extent that we have withholding responsibility in respect of the securities, we intend to so withhold.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">You should read carefully the discussion under &ldquo;United
States Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement
and &ldquo;United States Federal Tax Considerations&rdquo; in this pricing supplement. You should also consult your tax adviser regarding
the U.S. federal tax consequences of an investment in the securities, as well as tax consequences arising under the laws of any state,
local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The tax disclosure is subject to confirmation.</B> The information set forth under &ldquo;United States Federal Tax Considerations&rdquo;
in this pricing supplement remains subject to confirmation by our counsel following the pricing of the securities. If that information
cannot be confirmed by our counsel, you may be asked to accept revisions to that information in connection with your purchase. Under these
circumstances, if you decline to accept revisions to that information, your purchase of the securities will be canceled.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Information About the iShares<SUP>&reg;</SUP> MSCI EAFE
ETF</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The iShares<SUP>&reg;</SUP> MSCI EAFE ETF is an exchange-traded fund
that seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of publicly
traded securities in certain developed markets, excluding the United States and Canada, as measured by the MSCI EAFE<SUP>&reg;</SUP> Index.
However, for purposes of the securities, the performance of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF will reflect only its price performance,
as any dividends paid on the shares of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF will not be factored into a determination of the closing
price of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF. The MSCI EAFE<SUP>&reg;</SUP> Index was developed by MSCI Inc. as an equity benchmark
for international stock performance, and is designed to measure equity market performance in certain developed markets, excluding the
United States and Canada. The iShares<SUP>&reg;</SUP> MSCI EAFE ETF is an investment portfolio managed by iShares<SUP>&reg;</SUP> Trust.
BlackRock Fund Advisors is the investment adviser to the iShares<SUP>&reg;</SUP> MSCI EAFE ETF. iShares<SUP>&reg;</SUP> Trust is a registered
investment company that consists of numerous separate investment portfolios, including the iShares<SUP>&reg;</SUP> MSCI EAFE ETF.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Information provided to or filed with the SEC by iShares<SUP>&reg;</SUP>
Trust pursuant to the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as amended, can be located by reference
to SEC file numbers 333-92935 and 811-09729, respectively, through the SEC&rsquo;s website at http://www.sec.gov. In addition, information
may be obtained from other sources including, but not limited to, press releases, newspaper articles and other publicly disseminated documents.
The underlying shares of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF trade on the NYSE Arca under the ticker symbol &ldquo;EFA.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Fund Descriptions&mdash; The iShares<SUP>&reg;</SUP>
ETFs&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding the iShares<SUP>&reg;</SUP>
MSCI EAFE ETF from publicly available information and have not independently verified any information regarding the iShares<SUP>&reg;</SUP>
MSCI EAFE ETF. This pricing supplement relates only to the securities and not to the iShares<SUP>&reg;</SUP> MSCI EAFE ETF. We make no
representation as to the performance of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF is not involved in any way in this
offering and has no obligation relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the iShares<SUP>&reg;</SUP> MSCI EAFE ETF on October
22, 2025 was $94.45.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of the iShares<SUP>&reg;</SUP>
MSCI EAFE ETF for each day such value was available from January 2, 2015 to October 22, 2025. We obtained the closing values from Bloomberg
L.P., without independent verification. You should not take historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>iShares<SUP>&reg;</SUP> MSCI EAFE ETF &ndash; Historical Closing Values</B></FONT><B><FONT STYLE="color: white"><BR>
</FONT><FONT STYLE="color: #59AE43">January 2, 2015 to October 22, 2025</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Information About the Russell 2000<SUP>&reg;</SUP> Index</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Russell 2000<SUP>&reg;</SUP> Index is designed to track the performance
of the small capitalization segment of the U.S. equity market. All stocks included in the Russell 2000<SUP>&reg;</SUP> Index are traded
on a major U.S. exchange. It is calculated and maintained by FTSE Russell.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;
The Russell Indices&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding the Russell 2000<SUP>&reg;</SUP>
Index from publicly available information and have not independently verified any information regarding the Russell 2000<SUP>&reg;</SUP>
Index. This pricing supplement relates only to the securities and not to the Russell 2000<SUP>&reg;</SUP> Index. We make no representation
as to the performance of the Russell 2000<SUP>&reg;</SUP> Index over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the Russell 2000<SUP>&reg;</SUP> Index is not involved in any way in this offering
and has no obligation relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the Russell 2000<SUP>&reg;</SUP> Index on October
22, 2025 was 2,451.552.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of the Russell 2000<SUP>&reg;</SUP>
Index for each day such value was available from January 2, 2015 to October 22, 2025. We obtained the closing values from Bloomberg L.P.,
without independent verification. You should not take historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Russell 2000<SUP>&reg;</SUP> Index &ndash; Historical Closing Values</B></FONT><B><FONT STYLE="color: white"><BR>
</FONT><FONT STYLE="color: #59AE43">January 2, 2015 to October 22, 2025</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Information About the S&amp;P 500<SUP>&reg;</SUP> Index</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The S&amp;P 500<SUP>&reg;</SUP> Index consists of the common stocks
of 500 issuers selected to provide a performance benchmark for the large capitalization segment of the U.S. equity markets. It is calculated
and maintained by S&amp;P Dow Jones Indices LLC.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;
The S&amp;P U.S. Indices&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding the S&amp;P 500<SUP>&reg;</SUP>
Index from publicly available information and have not independently verified any information regarding the S&amp;P 500<SUP>&reg;</SUP>
Index. This pricing supplement relates only to the securities and not to the S&amp;P 500<SUP>&reg;</SUP> Index. We make no representation
as to the performance of the S&amp;P 500<SUP>&reg;</SUP> Index over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the S&amp;P 500<SUP>&reg;</SUP> Index is not involved in any way in this offering
and has no obligation relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the S&amp;P 500<SUP>&reg;</SUP> Index on October
22, 2025 was 6,699.40.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of the S&amp;P 500<SUP>&reg;</SUP>
Index for each day such value was available from January 2, 2015 to October 22, 2025. We obtained the closing values from Bloomberg L.P.,
without independent verification. You should not take historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>S&amp;P 500<SUP>&reg;</SUP> Index &ndash; Historical Closing Values</B></FONT><B><FONT STYLE="color: white"><BR>
</FONT><FONT STYLE="color: #59AE43">January 2, 2015 to October 22, 2025</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">United States Federal Tax Considerations</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Due to the lack of any controlling legal authority, there is substantial
uncertainty regarding the U.S. federal tax consequences of an investment in the securities. In connection with any information reporting
requirements we may have in respect of the securities under applicable law, we intend (in the absence of an administrative determination
or judicial ruling to the contrary) to treat the securities for U.S. federal income tax purposes as prepaid forward contracts with associated
coupon payments that will be treated as gross income to you at the time received or accrued in accordance with your regular method of
tax accounting. We expect that our counsel will advise us that, based on current market conditions, this treatment of the securities is
reasonable under current law, but that it is unable to conclude affirmatively that this treatment is more likely than not to be upheld,
and that alternative treatments are possible. The information set forth under this section remains subject to confirmation by our counsel
following the pricing of the securities. If that information cannot be confirmed by our counsel, you may be asked to accept revisions
to that information in connection with your purchase. Under these circumstances, if you decline to accept revisions to that information,
your purchase of the securities will be canceled.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming this treatment of the securities is respected and subject to
the discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following U.S. federal
income tax consequences should result under current law:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Any coupon payments on the securities should be taxable as ordinary income to you at the time received or accrued in accordance with
your regular method of accounting for U.S. federal income tax purposes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Upon a sale or exchange of a security (including retirement at maturity), you should recognize capital gain or loss equal to the difference
between the amount realized and your tax basis in the security. For this purpose, the amount realized does not include any coupon paid
on retirement and may not include sale proceeds attributable to an accrued coupon, which may be treated as a coupon payment. Such gain
or loss should be long-term capital gain or loss if you held the security for more than one year.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We do not plan to request a ruling from the IRS regarding the treatment
of the securities. An alternative characterization of the securities could materially and adversely affect the tax consequences of ownership
and disposition of the securities, including the timing and character of income recognized. In addition, the U.S. Treasury Department
and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo;
and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance.
Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury
regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences
of an investment in the securities, possibly with retroactive effect. You should consult your tax adviser regarding possible alternative
tax treatments of the securities and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Withholding Tax on Non-U.S. Holders.</B> Because significant aspects
of the tax treatment of the securities are uncertain, persons having withholding responsibility in respect of the securities may withhold
on any coupon payment paid to Non-U.S. Holders (as defined in the accompanying product supplement), generally at a rate of 30%. To the
extent that we have (or an affiliate of ours has) withholding responsibility in respect of the securities, we intend to so withhold. In
order to claim an exemption from, or a reduction in, the 30% withholding, you may need to comply with certification requirements to establish
that you are not a U.S. person and are eligible for such an exemption or reduction under an applicable tax treaty. You should consult
your tax adviser regarding the tax treatment of the securities, including the possibility of obtaining a refund of any amounts withheld
and the certification requirement described above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&rdquo; in the accompanying product supplement, Section 871(m) of the Code and Treasury regulations promulgated
thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;U.S. Underlying Equities&rdquo;) or indices that
include U.S. Underlying Equities. Section 871(m) generally applies to instruments that substantially replicate the economic performance
of one or more U.S. Underlying Equities, as determined based on tests set forth in the applicable Treasury regulations. However, the regulations,
as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo; of one.
Based on the terms of the securities and market conditions as of the date of this preliminary pricing supplement, we expect that the securities
will not be treated as transactions that have a &ldquo;delta&rdquo; of one within the meaning of the regulations with respect to any U.S.
Underlying Equity and, therefore, should not be subject to withholding tax under Section 871(m). However, the final determination regarding
the treatment of the securities under Section 871(m) will be made as of the pricing date for the securities, and it is possible that the
securities will be subject to withholding tax under Section 871(m) based on the circumstances as of that date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A determination that the securities are not subject to Section 871(m)
is not binding on the IRS, and the IRS may disagree with this treatment. Moreover, Section 871(m) is complex and its application may depend
on your particular circumstances, including your other transactions. You should consult your tax adviser regarding the potential application
of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We will not be required to pay any additional amounts with respect to
amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under the laws
of any state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Supplemental Plan of Distribution</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
underwriter of the sale of the securities, is acting as principal and will receive an underwriting fee of up to $20.00 for each security
sold in this offering. The actual underwriting fee will be equal to the selling concession</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">provided to selected dealers, as described in this paragraph. From this
underwriting fee, CGMI will pay selected dealers not affiliated with CGMI a variable selling concession of up to $20.00 for each security
they sell. For the avoidance of doubt, any fees or selling concessions described in this pricing supplement will not be rebated if we
redeem the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See &ldquo;Plan of Distribution; Conflicts of Interest&rdquo; in the
accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying prospectus supplement and prospectus
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Valuation of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the securities set forth on the
cover page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s proprietary pricing models generated an estimated
value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate the payout on
the securities, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;) and one or more derivative instruments underlying
the economic terms of the securities (the &ldquo;derivative component&rdquo;). CGMI calculated the estimated value of the bond component
using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the securities prior to maturity will fluctuate
based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or Citigroup Inc.&rsquo;s creditworthiness.
These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The estimated value of the securities is a function of the terms of
the securities and the inputs to CGMI&rsquo;s proprietary pricing models.&nbsp;&nbsp;As of the date of this preliminary pricing supplement,
it is uncertain what the estimated value of the securities will be on the pricing date because certain terms of the securities have not
yet been fixed and because it is uncertain what the values of the inputs to CGMI&rsquo;s proprietary pricing models will be on the pricing
date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For a period of approximately three months following issuance of the
securities, the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will be indicated
for the securities on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one
or more financial information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.
This temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the
term of the securities. The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the three-month
temporary adjustment period. However, CGMI is not obligated to buy the securities from investors at any time.&nbsp;&nbsp;See &ldquo;Summary
Risk Factors&mdash;The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Contact</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Clients may contact their local brokerage representative. Third-party
distributors may contact Citi Structured Investment Sales at (212) 723-7005.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&copy; 2025 Citigroup Global Markets Inc. All rights reserved. Citi
and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout the
world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ D$# 2(  A$! Q$!_\0
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M3?F/\* )OM%]_P ]H/\ OR?_ (JC[1??\]H/^_)_^*J'R#_S\3?F/\*/(/\
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MR#_S\3?F/\*/(/\ S\3?F/\ "@";[1??\]H/^_)_^*H^T7W_ #V@_P"_)_\
MBJA\@_\ /Q-^8_PH\@_\_$WYC_"@";[1??\ /:#_ +\G_P"*H^T7W_/:#_OR
M?_BJA\@_\_$WYC_"CR#_ ,_$WYC_  H F^T7W_/:#_OR?_BJ/M%]_P ]H/\
MOR?_ (JH?(/_ #\3?F/\*/(/_/Q-^8_PH F^T7W_ #V@_P"_)_\ BJ/M%]_S
MV@_[\G_XJH?(/_/Q-^8_PH\@_P#/Q-^8_P * )OM%]_SV@_[\G_XJC[1??\
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MIDTHAA:1E9@HZ(I8GZ 5375876P813?Z: 4^7A,J6^8].U %^N>TC_D#V?\
MUR6M.SU-+R4H(GC!3S8V8C#IG&X8/'X^HK*TAE_L>S^8?ZI>] %ZBDW+_>7\
MZ-R_WE_.@!:*3<O]Y?SHW+_>7\Z %HI-R_WE_.C<O]Y?SH 6BDW+_>7\Z-R_
MWE_.@!:*3<O]Y?SHW+_>7\Z %HI-R_WE_.C<O]Y?SH 6BDW+_>7\Z-R_WE_.
M@!:*3<O]Y?SHW+_>7\Z %HI-R_WE_.C<O]Y?SH 6BDW+_>7\Z-R_WE_.@!:*
M3<O]Y?SHW+_>7\Z %HI-R_WE_.C<O]Y?SH 6BDW+_>7\Z-R_WE_.@!:*3<O]
MY?SHW+_>7\Z %HI-R_WE_.C<O]Y?SH 6BDW+_>7\Z-R_WE_.@!:*3<O]Y?SH
MW+_>7\Z %HI-R_WE_.C<O]Y?SH 6BDW+_>7\Z-R_WE_.@!:*3<O]Y?SHW+_>
M7\Z %HI-R_WE_.C<O]Y?SH 6BDW+_>7\Z-R_WE_.@!:*3<O]Y?SHW+_>7\Z
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MPB_[X%244 1_9X/^>$7_ 'P*/L\'_/"+_O@5)10!']G@_P">$7_? H^SP?\
M/"+_ +X%244 1_9X/^>$7_? H^SP?\\(O^^!4E% $?V>#_GA%_WP*/L\'_/"
M+_O@5)10!']G@_YX1?\ ? H^SP?\\(O^^!4E% $?V>#_ )X1?]\"C[/!_P \
M(O\ O@5)10!']G@_YX1?]\"C[/!_SPB_[X%244 1_9X/^>$7_? H^SP?\\(O
M^^!4E% $?V>#_GA%_P!\"C[/!_SPB_[X%244 1_9X/\ GA%_WP*/L\'_ #PB
M_P"^!4E% $?V>#_GA%_WP*/L\'_/"+_O@5)10!']G@_YX1?]\"C[/!_SPB_[
MX%244 1_9X/^>$7_ 'P*/L\'_/"+_O@5)10!']G@_P">$7_? H^SP?\ /"+_
M +X%244 1_9X/^>$7_? H^SP?\\(O^^!4E% $?V>#_GA%_WP*/L\'_/"+_O@
M5)10!']G@_YX1?\ ? H^SP?\\(O^^!4E% $?V>#_ )X1?]\"C[/!_P \(O\
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M '$W^J7^$?XUT<<$,+.T42(SG<Y50"Q]3ZUA:1_R![/_ *Y+0!/YY_Y]Y_\
MOD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]
MY_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%Y
MY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+1
M0!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?
MXU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?
M_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?
M^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?X
MT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\
MOD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]
MY_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%Y
MY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+1
M0!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?
MXU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?
M_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?
M^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?X
MT>>?^?>?_OD?XU+10!%YY_Y]Y_\ OD?XT>>?^?>?_OD?XU+10!%YY_Y]Y_\
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M/DS1\E0<@J>X-$:].5DGN$:T)62>YM448/I16QJ%%%% !1110 4444 %%%%
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M?]_&_P :/LT?_33_ +^-_C4U% $/V:/_ *:?]_&_QH^S1_\ 33_OXW^-344
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M0++*9'AD*<G) ZC/ZUO9/K7H4YJ<5)=3MA)3BI+J0?:X/^>G_CK?X4?:X/\
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MGT ]:Q1XZ3[20;%OL^>"'^?\NE*=>G"UWN*5:G&UWN=?16<VL0IIQO\ "&V
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M$T/PS<7EX#?V\T5JN=Q)VDGL.><>XJBM]*FF2:.N\![K)[\=,?F :]*\R?\
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M'W)(N<C\*LVZ2VUM% D!*QH$!:49( ^E;T,.Z4V^EC>C0=*;?2Q:HJ'S)_\
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M4 345#YD_P#S[#_OZ*/,G_Y]A_W]% $U%0^9/_S[#_OZ*/,G_P"?8?\ ?T4
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ME_\ GYE_)?\ "IJ* (?)?_GYE_)?\*/)?_GYE_)?\*FHH A\E_\ GYE_)?\
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M_DO^%'DO_P _,OY+_A4U% $/DO\ \_,OY+_A1Y+_ //S+^2_X5-10!#Y+_\
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M93S$+XQ(F<;A@_SQU%96D?\ ('L_^N2UI6>F+:N2TGFJ(_*C4J $CS]WW_\
MK5CZ3:VYT>S)@C_U2_PB@#2HJ+[+;_\ /"/_ +Y%'V6W_P">$?\ WR* ):*B
M^RV__/"/_OD4?9;?_GA'_P!\B@"6BHOLMO\ \\(_^^11]EM_^>$?_?(H EHJ
M+[+;_P#/"/\ [Y%'V6W_ .>$?_?(H EHJ+[+;_\ /"/_ +Y%'V6W_P">$?\
MWR* ):*B^RV__/"/_OD4?9;?_GA'_P!\B@"6BHOLMO\ \\(_^^11]EM_^>$?
M_?(H EHJ+[+;_P#/"/\ [Y%'V6W_ .>$?_?(H EHJ+[+;_\ /"/_ +Y%'V6W
M_P">$?\ WR* ):*B^RV__/"/_OD4?9;?_GA'_P!\B@"6BHOLMO\ \\(_^^11
M]EM_^>$?_?(H EHJ+[+;_P#/"/\ [Y%'V6W_ .>$?_?(H EHJ+[+;_\ /"/_
M +Y%'V6W_P">$?\ WR* ):*B^RV__/"/_OD4?9;?_GA'_P!\B@"6BHOLMO\
M\\(_^^11]EM_^>$?_?(H EHJ+[+;_P#/"/\ [Y%'V6W_ .>$?_?(H EHJ+[+
M;_\ /"/_ +Y%'V6W_P">$?\ WR* ):*B^RV__/"/_OD4?9;?_GA'_P!\B@"6
MBHOLMO\ \\(_^^11]EM_^>$?_?(H EHJ+[+;_P#/"/\ [Y%'V6W_ .>$?_?(
MH EHJ+[+;_\ /"/_ +Y%'V6W_P">$?\ WR* ):*B^RV__/"/_OD4?9;?_GA'
M_P!\B@"6BHOLMO\ \\(_^^11]EM_^>$?_?(H EHJ+[+;_P#/"/\ [Y%'V6W_
M .>$?_?(H EHJ+[+;_\ /"/_ +Y%'V6W_P">$?\ WR* ):*B^RV__/"/_OD4
M?9;?_GA'_P!\B@"6BHOLMO\ \\(_^^11]EM_^>$?_?(H EHJ+[+;_P#/"/\
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M_OW0!-14/VC_ *8S_P#?NC[1_P!,9_\ OW0!-14/VC_IC/\ ]^Z/M'_3&?\
M[]T 345#]H_Z8S_]^Z/M'_3&?_OW0!-14/VC_IC/_P!^Z/M'_3&?_OW0!-14
M/VC_ *8S_P#?NC[1_P!,9_\ OW0!-14/VC_IC/\ ]^Z/M'_3&?\ []T 345#
M]H_Z8S_]^Z/M'_3&?_OW0!-14/VC_IC/_P!^Z/M'_3&?_OW0!-14/VC_ *8S
M_P#?NC[1_P!,9_\ OW0!-14/VC_IC/\ ]^Z/M'_3&?\ []T 345#]H_Z8S_]
M^Z/M'_3&?_OW0!-14/VC_IC/_P!^Z/M'_3&?_OW0!-14/VC_ *8S_P#?NC[1
M_P!,9_\ OW0!-14/VC_IC/\ ]^Z/M'_3&?\ []T 345#]H_Z8S_]^Z/M'_3&
M?_OW0!-14/VC_IC/_P!^Z/M'_3&?_OW0!-14/VC_ *8S_P#?NC[1_P!,9_\
MOW0!-14/VC_IC/\ ]^Z/M'_3&?\ []T 345#]H_Z8S_]^Z/M'_3&?_OW0!-1
M4/VC_IC/_P!^Z/M'_3&?_OW0!-14/VC_ *8S_P#?NC[1_P!,9_\ OW0!-14/
MVC_IC/\ ]^Z/M'_3&?\ []T 345#]H_Z8S_]^Z/M'_3&?_OW0!-14/VC_IC/
M_P!^Z/M'_3&?_OW0!-14/VC_ *8S_P#?NC[1_P!,9_\ OW0!-14/VC_IC/\
M]^Z/M'_3&?\ []T 345#]H_Z8S_]^Z/M'_3&?_OW0!-14/VC_IC/_P!^Z/M'
M_3&?_OW0!-14/VC_ *8S_P#?NC[1_P!,9_\ OW0!-14/VC_IC/\ ]^Z/M'_3
M&?\ []T 340?\A2#_KE)_-*A^T?],9_^_=/M)-^JP_)(N(I/OKCNM &Q1110
M 4444 %126L$LR320QM+']QRH)7Z&I:* (HK:"!I&AACC:0[G*J 6/J:P](_
MY ]G_P!<EKH:Y[2/^0/9_P#7): +E%%% !1110 4444 %%%% !1110 4444
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MOLZ_WYO^_K?XT?9U_OS?]_6_QH EHJ+[.O\ ?F_[^M_C1]G7^_-_W];_ !H
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M: +-%5O[1L?^?ZU_[_+_ (T?VC8_\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\
MC1_:-C_S_6O_ '^7_&@"S15;^T;'_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-
M%5O[1L?^?ZU_[_+_ (T?VC8_\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:
M-C_S_6O_ '^7_&@"S15;^T;'_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[
M1L?^?ZU_[_+_ (T?VC8_\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S
M_6O_ '^7_&@"S15;^T;'_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L?^
M?ZU_[_+_ (T?VC8_\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S_6O_
M '^7_&@"S15;^T;'_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L?^?ZU_
M[_+_ (T?VC8_\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S_6O_ '^7
M_&@"S15;^T;'_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L?^?ZU_[_+_
M (T?VC8_\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S_6O_ '^7_&@"
MS15;^T;'_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L?^?ZU_[_+_ (T?
MVC8_\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S_6O_ '^7_&@"S15;
M^T;'_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L?^?ZU_[_+_ (T?VC8_
M\_UK_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S_6O_ '^7_&@"S15;^T;'
M_G^M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L?^?ZU_[_+_ (T?VC8_\_UK
M_P!_E_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S_6O_ '^7_&@"S15;^T;'_G^M
M?^_R_P"-']HV/_/]:_\ ?Y?\: +-%5O[1L?^?ZU_[_+_ (T?VC8_\_UK_P!_
ME_QH LT56_M&Q_Y_K7_O\O\ C1_:-C_S_6O_ '^7_&@"S15;^T;'_G^M?^_R
M_P"-']HV/_/]:_\ ?Y?\: +-$'_(4@_ZY2?S2JW]HV/_ #_6O_?Y?\:DLKJW
MN-5A$%Q#*1%(2(W#8Y3TH VJ*** "BBB@ HHHH Y[4[>[TJ-;C3&61@'3RIY
M54 ;&V*I.. V.,]._%6M(1O,FC,J3VZ*FPL8RP8YW#Y  %Z =\@]L58U>+3I
M+!I-3B22WA82?,F[:P/! '.>W'7..]1:+)%(EQY>G_8R)" /L[1;TR=IY R<
M?E0!CR2ZD9YUEEMXY(%?[.ZR0XD8R-A7!Y "[,@8/!Y)Q6MK3WEK:13626[2
M*S;TD95#_(V "?\ ;VGJ. :I7C:'9ZI+']FT]+F21);@W&U<JP(+KGJ?E[5I
MZREA)88U&W,]N&#8$1?:1R&X&1C'6@"KHRR>9(C2QS0"-",F,LKG)8#9P%'
MY[Y[5G7$NH&ZG222"(P"5H)$DA^=BYV*P;D )MSTZ'DUI:#>6=V;O[+;0P;)
M,#RXMFY/X2>!SUXK/O[K0K74KI4L89;S?&]R&M7;<#D$J=I!; [=>* -B_6=
M=-#1-#',"A=^ ,9&X*6X!(R!FLSP_)>3S@W(108V::)GA;]YD8,?EYPO7.XD
M\CWK:O(;2\TV6.]A1K1X\R)*O 7&>1VQ^E9^BSVDUU-]ET[R(=BF&;[*T?F(
M0,Y)4=^W?K0!0U62^BU3R]P-L7W#R'@1X@%&W_6>IW9Z\%<8YSJ2+=?V%&YD
MMUN]B&25,!3R-VTGC)&<9XSBJFLG2+2^:66ULCJ$\65:YPJR*I Y8\9 ;ZUI
MW26,^D.DL"W%B\8'EQQ^8&0],*HY'TH QM"DO9[O-QY:J0[31L\+#=GY3&$)
M(&.NX]Q3M<>\AO%6,H;5RF4B:%9%'S$M^\XSG9CV#=\&I-$O=-FU&:"RM8HU
M2-?+D6$JS#^+)(]<?6EUV;1[:^C>ZM8I=1:!Q 7@9E('.UF ( SZ^^* )U2\
ME\.2LLL"WK1OY<QVD+R=I8@;<@8S@8R#19AUO GV[3[E&SNQ&%E.!QT.#^0J
MW8FVO-+0);JMNZE3$T6U2,D'Y2.AY[<@UEZ2^FKJ$<&G::%M4C*QW*VSCY@2
M" Y7&,#KGF@">^BG_M!S]OM+>W\I-D,T:L&;+;B1P?[N.>QXJ["))=.+%K5Y
MRK;7B'R9YQUS5/6UTF&:WNKZWMVN2&A@DG VYP6VL3P <=ZO:<\$FFPO L C
M*\K;D% ?X@,=><T 9EB+B-K=9=2TZYD8*LNZ-1(3W *D \DX^6I]2AG-Y%LO
M;:UMO*8,DJ*P=\C&0<$C&>A'6LZSN=$MM4M;.RTZ*(%G)+6K(\;D@J "O Y;
MZ8%:.N2:-"]G+JT"R,)=L#&!I"K$8/0' QZ\=* +5AF6W)F>TF8,0&MUPN/S
M/-<[))JHNC_I%OYH^52KPA V>X/S>7C' ^;(/M6YH5Q%<:?NBMDMR&PZQQE$
M+8&2N0,CH,^H/I5"4:3::F8;;2DED:XW73):,XC+)G.0I&2=A(_VB: +FM_:
M8H8FLWABY.XL5!)Q\OWN,9Z]\9QS46@"X=)A<,CQJ$" F-BK<[L;. G3 //7
M-6]:33C8&?5(4DMX'63++NV$'AOUY]L]J;H\MI+%-]E6R4B1@1:LI&W)V$X[
MD<XH P[F35!=.!<0;U+A"KPA0V?ESN^;R\ ;A][(.*VM8\^*WC:V:*/Y_G)*
MJQ&#C!;CKC/MG'-95U<Z'9:@5338_.FN-UP9+5AV(+KE>22!TZY)K6UYM+CT
MWS=6A$ELDBL!Y1D(;/!  )H J^'Q<N)5N6C>-50 9C;#\[MNSHG3 //7-4=2
M_M!]195NUMQ%*60H\&PQ[> 0X+;\GZ>]:FB75K.URMM:QP[7^]%"45ER=N20
M,M@<CMD>M5M472[6^D=-,2YU"81M*%MFDRF[:6.%.#C=CUVX[4 6[TW4>C12
M)]G%QA/.9"H!'&[86XSUQGBJ6@)=BYD$]TD\#!W"2&)I$)8;?]6 .F[/7^'!
MZUJWT%E<Z3+'=VXDM/+W-$R=@,].H(QQW!JGHUSIMQ/,;%;$*0IC,!7>R%02
M6 Y'S9'X4 9VJ"^?4C&MT+=8Y0R-&\ 7R]O((<%M^2<=NG/6M>47:Z$)%^RF
M^$*DMP(RV!G!/;KC/M6;K,^D65W-.^G1R7TFQ6:6V;;(H(YW8P2 3S]!6W+]
MCETMO-B1K)XOF1H\@ICIMQZ=J ,+1UO#JC,UT)+:1B3#.T+2* HY_=CKN]SQ
MUYQ2ZK<,FL_97G<1LJ&&&U:$,#DY+^9[@8P>U/T6^TB:[ACTVS58F@4Q2"V9
M7'!W!R5&. O)/))JWJLEK8-/*L#37EW"56!8V<3%!QN"@X R!GWH 0/=?\(W
M-,9K,7B+(/.;'EJ58CYCTR,8/;(-4=*N'GO()(9I6MY9"LOVIH3O.PD! @SN
MX!YQ\H-:EEIUFVA"R$4OV60,2D^[?\S%CG=SU)ZU1M;G3=5UBUF26)GMU)B/
MG;96D =&#IW !SSW)H ;K]P;>]BA>?R[:6,XB@,0D9L]3YG&W'ZU=T\W#Z?=
M>;) T\;NJ%]I*< J)-O&><G':EU*XL-/NUN[E91(T9B++$S*RYSM; (ZYQ]3
M46@0V<NB,T<1"71+W$;%BH<@!E&>=HQ@>U &5IUW-/)#+'=%V\R-+B29H#"P
M)P0@4;N2?E^M:^N3M:);>5<V-L))-KBYB+;EQSM (Y'7TQZ5FK>:1J%QIUM"
MMQ+';R[4?RY%=71U"@\<IPQ)/'R@UNZ@;2V,5_<EU: [$9 68[R!MP,DY.WC
MU H ;IX!5XI+BUN'3:?W$6P*I''&XUDVUW)+-<22:KI&V!R"4MB3Y>>Y+\>A
MZC(_"KN@Q1;;JZ6UEMIIY?WD;JZKA>%VA@, K@G'&2:HWBZ.X30VDB2*&8+(
MDDWEO&I7<OE]R"=JX],CM0!?UN=K.&!H;FRMB\H5OM,9;<O?: 1R.OX=NM3Z
M<!AXI+FTN&5591!#L"J<XXW'@X./I1J<EG;/;WETLH:%CLDCC9MN1R#@' /'
M7VJGX>:SN'O;VVC:.6:3;(OS;<*6V$ ],J<D#N30! US-)J=Y&-3TJ,09V#[
M,6=5QE@QWCD8YQ[=*N:Q*(M/@FCNHK>)I$\R90NXH?[F01G..QXSCFLW5+W2
M4CO=*"RN6DWSQA)!M$A.\QL!][[QX/4^];5S%9QZ;%-<;HH;-1,KG(:/:O7\
ML@_4T 4M.>4ZH(1-:SV/V;S(W38&=M_)*@=O4<$GH#55YY3>7ZI?VTEY"SF&
MV8($"[>!G&5;!YR3],5<TH0W.KWE\+2X@EP(E+QR(KQ\'=A@!NW9!QS@"H=4
M?2[47&G2/%&URRSNDTOE@*[8=T;LP 8\=\>M #[R:5/#UI<-=0PNPB,\R[<D
M'&[9D$9/;CZ=J73WE.J10K/;3V+6SR(Z[0[MO7DJ!VR<D<9/3-6KJ"R@TJW5
MUE:"VV-$T2L[+M'!X!/3O5+2;BPU'7+N]@1EF1/+4C< \9VDL5(QNW CUP!0
M 3/NUV6W>_@1U*-;VQ5"IXY#<;@Q.<<],8!YI8[FZ'A(7DKV@O!&6>0LI0<\
MX(P"0.!VSUI-4O\ 3]/N;N +NO;F+S3$\;F-RN%!) (!QM'X>U6[*PL9?#\%
MI&DXM-@*";<)!@Y!.><YP>: *&F/*;VW;[=;W,,_F;\(B D?="J!NWXY;/'T
MXHU"2636_L7VZVMXL(RQJB&1NO0M]UMP&,C!&>_22SEM-4UR*\CM[C;%"&M[
MDQ2(LNX$-G( /&W!]SBI=5FL=.>=F\H7-[$VU)VVQ2L@& Q/ /('T'M0!+:2
M3OH!G=K5KM8W^<D; PSC<1QQCG'&0<5EZ?/-+-:W":A!.DTPCD4I&@"[,@$#
MDONS@@XP*U[2RT^+0?LL&;BP:-Q]XR%U;);GJV<FLM;S3M1UNPMRLS-;Y9)'
M5T?S%! 5@0,C!8\]Q0!-K,S)J,%I]LM;6&5 <.BLS?-ALYZ<?=/3/7TJ]I'F
M26LJW+1R21S.@/RE@ > ^WC=CKBHM3O-.TZ^BEN2XN+F,PJ!&S*X + -@' '
M/YT>'H[?^R2T,4D8FD9Y5?=C>?O;=W.W/ ]A0!A6EQ>MJ]N6UB"XM$9A//'#
M$%89 13QN&6..,@^O:M?Q"[6Z6YBO[>TW,0T4D:DS#'0$@XQ],<\XZU7G%A-
M/9Z3%;3RV]K*%:5(Y/W+*59%W 8(Z @G&!S6MJ4EE9&'4;MC'Y1\H2#H Y P
MWMD*?P% %3PWY\FF 7\PFNP<NK1QJ8P>5!"<?=P?QK%AN+PZO#_Q.8)K6.1O
M/GCAA"A.RG/S#YL#(R#ZCI6[H$=KY-Q<P&'S)Y<S+!-YB*0  !Z?* <>I-95
MU/I,GV+1_)G$*RA2'21'B Y0+QG&0HQTQ0!JZ^S6]@DD%[!9/Y@&Z2,,).OR
M#@X/?(!Z=*K^&C.\,ZWLZROO+0Q&.(%(LD*?DX(.#S[5>UB>QLK>*^OC(JV\
M@9'C1F8,<CHH)Y!(/UJIHCVMSJ-_=0Q,DK[5+*'$;(&8J1N  8Y)('J,T 9;
M7MY+=7D37%NLEFLC1O&\6&.]L!\C(54V;L8/!YSBM;7+N:PTZ&[M_LV0WSJY
M"B3*-M SU^?:<>@-5=6^P)#+I"6T\ZRR;YTBCD8PK)G<RLH.TD[CC/<UK:@M
MK!8K<W <1V7[Y63.Y=JD$_\ ?)(^A- %'12YE\IYHY8F@250QC+!B3NQL&-H
M/'U!K-EO+N74+JV,\"O:B:2-XWB^9MQVJVX< )C..>#STK4TDV5UJ=[?020-
M,V(_W$^\&/)(8KT5B2V?7 JCJ]WIEM!<:>T4V)YB959)%VAC\[HP'7EB".^:
M -+49W@T>.[C>V5E:)Y') 1DW#< 2.XSCZBJ>A3W$DEL\DT?^DPO)+%NC^60
M$9";><#/.<]5[YK2O8[*'1O](WBUMU5P5!++MP5(QSD$"L[3KNQU37OMD,3[
MA ?*D".H*ML+;P0 &R !WP#0!T-%%% !1110 4444 9/B22)-"N8Y6MQYJ^6
MJSD;6SU'/&<9QGO65X,216OOWPFA^15;<A)8%LD;>Q&T\]R1VKJZKPV44%U/
M<KO::; 9F8G"C.%'H!DG\30!R.OS2W.KS1V-_#-,Z"&W1?-9K>8!BQ^3Y<X&
M<,1]WGCBNGN(]1ETORD%M]J==KEB2@'/(RIR>G48IMSH>G7-PMR;<1W",66:
M$F-PQ!&<KC/!/6M&@#G/#UE+:ZK?&XCW3^7&C31H%C(!8A>$7)&<YYZBJ^J/
M=73:A>6HG2Q6-K:Y8.A9E0L&,:GH1EADD9QTZ9ZNL^;1-.GF>62WR9#ND4.P
M1SZLH.UOQ% #[B>&#1VE\Z,1>5A7G/RG(P-Q]^*Y3P;$\>JLL4L;0+;D,JM'
MA22I4*%.>/G![<*>]=Q5?[%%_:'VT[VF$9C7+'"*2"<#H,X&?H* .;\37*'4
M8$6[@D$:%)+0F4L)'*B-L1<@]OF]>,5L:<FJQ:%"ERT$M^L:C<Q8*QP,ENI!
MZ^M2WNC:=J#A[FU1I RL)%RK@@Y!W#!X(%78T\N)4W,VT ;F.2?J: .8TK3K
MFU\1QM>(LLJP/MD@151 2.&(C7.<<#)Q@\5;U9[JZU*.#30_VJS7S6=G"Q@.
M" ""#N. ?3'KSBMZJ=WI=I>RB6:-O-"[=\<C1L5]"5()'L: *^C2PQ:()#)(
M%1I3,TY *N';>#C@ -NQCC KE=#1CXGB>":W96EDDD2%H]FTA\X .[.2A'KE
MLXQ7=0016L"001K'$@PJ*, "HYK*&>[@N)-[- 28UW':&(QNQW."1^)H Q/%
M=U'%';H;V",1L9I[>0OF6(*<G$>6P#@],<5;\.QZC%IA6^*$[F,0^<%5+'"D
M-SP, 9Y^G2KE_I-AJ<92]M(I@5*Y8<X/;/45/;P+;0K$KR,J]#(Y8_F>30!R
M]WIU^=6M)KY(9$>YC=8[9 6!# YW>7D =3EAD COBM37'EGDM["T60W9/VA"
M'"*H0CEL@Y&2.,?EC-;-5KO3[:^V&>,EHR2CJY1ESUPRD$4 4=!W;+P3M(;L
M7'^D!\85MBXVXXV[=I]>3GFN5UMA<>(I9K.YMO-9D1!&T?S,,8W[CGJ&!QT!
M4C)S7=6MG;V4/DV\81,ECR223U))Y)]S27ME#J%O]GGWF(D%E5BN\>AQU'M0
M!2\0S>7H\L:7T5G/+A(7D8C<V<[1CYCD CY>?2LWPL;N26>=/*&F2 ")5\T8
M89#%?,YY/7@#COR:Z&YM+>\C\NY@CE3.0'4'!]1Z&H=/TRVTN(PVBND).1&7
M+*G^[D\=>E '/>(M/U"X$TMPD$EJW[OR84#22#L 3&2&/KD 'N.M;.NR!K$6
M*I*TUZ3#&L;A#G!8DL>@ !['/3!K4J"[L[>^A$5Q&'4$,.2"I'0@CD'W% &5
MHWV@:E>+?NYO_*C+ ;?+\O+[2N.^=P.>>!VQ6'XM>&;5D*W,*M%%L;RS'YH)
M)R#O(Z94@=\-D]*Z^TL+:Q#_ &>,J9#EW9B[,?=B23^=27, N;=X6>1%<8+1
MMM8?0CI0!1>8VWAQ6N[J&TE^S*K3%QM1RN,@_7I6#X:^WOJ.Z)X&MHX_*NB!
M. \O!W#S._T_O<D\5U0LK;[&EF8(VMD4(L3+N4 =!@_2H+'2;/39)7LT:)93
MN>,.2A;CG:3@'CM0!F:_9ZC<%Y5:T2UC4_>C$C$'KD&-OR%78+B'2/#-O*\$
MT<<%O&HA;!<< !3VSG ]*U*9+%'/"\,R+)&X*LC#((/8T <UIUO=6>IZ?!J#
M3(BB06BB17R=N2)& !)QD],<<G.*B\9/#(]I%YUNLD1:0AF02#.,8W< $!AG
MUQVS706NDV5G-YT43>8%VAI)&D*KZ#<3@>PJVZ[T9<E=P(RIP1]* ,K0G^S>
M&[>2[F0*B,QE9E V;B06(.T';C.#@'-<]I#7\NL1?9+JWN7C=GN9_P!]B6-M
MVS)/R^A&W/W>,"NL$%GIFE21O@6D2.\IE.[(Y9BV>N<DFN=\,ZYX,UG59F\.
M:E;R783=+#!(RAE' )0X! SU XS0!M:S:ZA>1)%9FV5<Y9I0"<^P*L*J^'52
MQT6XEEC>-1+)+(Y7:'[EE4*N!QTP.A/.<G3NM4L;*2VCN;N*)[J7RH%9L&1\
M$X'J< U:RK97@^HH Y.,7/GVMS<?:(=.N;M9XU\Q6<.Q^4,>H4D@8!.,XZ5I
M>*7@_L5[>:2!/.90!+MY 8$E0>"P'(SWQ5N#1=/MIDEBM\&,YC4NS+&?]E2<
M+^ %:% ',^#%F%E<[Y%DC,B[6#(3NV@-]WC&X'&><'I6;J4\]YK<RZ;?03SR
M2+]F=/.8P!-HD7*_)C/)R?XN<\"NOMK&&UEN)8]YDG??([L23Z#V '057DT+
M3GNTNTMQ#<H21+ QC/)YSCKG'.: #4(=0N=.6*$6RS. )"YRH_W<J<\^HJAX
M:M'M;C4?.C/G%T#RJ@6-R 1A0$7IW.#G(YXXZ"B@#E-4>ZNFU"\M1.EBL;6U
MRP="S*A8,8U/0C+#)(SCITSKZI-!'X=F_>0[)+<I&;EOE<E> V?6I)M$TZ>9
MY9+?)D.Z10[!'/JR@[6_$5H4 <=X-1TO;H1S"6W$87):/.=QVX"'^Z1G/0@X
MS1XDN#+JICMKR"5_+$$< ,S-#/\ ,0W[O@$C^]C[O4<UU"6,*7\M[\[3R*$R
MS$A5'8#MSS4%WH>G7LRS2VRB=6WK-&2CAL8SN7!S0 B)J9T5(W-NU]L"LS$[
M3VSTZ^V,5E:'83VFO3FZ0/.MOM\V) L8!8':<(N3W[XP>F>>E5=JA<DX&,D\
MFEH Y_4GO;O5&_LM7$UDICD=G4(=X5MH4CEL;3G@<XSUQ<TJXM(/#MM,D[BU
M2(?O+@_,/][MU]./2I[K2+*\F,TT3>8R[6:.1DWCT;:1N'UJW%$D,211(J1H
M JJHP !T H X3PI$\>MQB*6%D$;&1(FCV*"!PH4[N&#?\!()YXK5\4W<2W-L
MANX"L08SVC&0LVX@(V(\G@\<C'S>N*WWLH9+^*\?>TL2E8P6.U<]2!Z]LU%?
MZ/I^IC_2[2.1N/GQAN#D?,.>O/6@"#0TU.+142_:-[H*=A^89] V<D>G<X'K
M61_9UZGB"RFOHXY<SM(@MD'[LX(W,WE@[><<MDY'6NHAB$$*Q!W<*,;G;<Q^
MI/6I* ,367N+F\@L[!6^UP8N=Y<*B@[E&X$'=GYN,<8SD<9F\/E3I\N7F:83
MR>>)<963/S 8XQZ8_G5J[TVUO722:-O,0$+)'(R, >HW*0<>U36UM#9P+!;Q
MK'$O11^9/UH X.8_:/%7GV=Q;,TMTC 1/'M8 IRV3N)*AAQW5<=:ZCQ+-MTP
M0)>Q6T\LB[%D+?O0&!9 %^8Y&1\OK6C=V4-Z(EGWE(Y!)L#$!B#D9]<'!^HI
M;JRM;U EU;QS =-ZYQ]#VH Q?"OVQH9IF,?]GS$26JCS 54J.F_G:>3VZ]*I
M:OIVH2W<<]Y'#+"\\>(;907)!!!#&/(QC))8=.HKI+"P@TVV%M;;UA7 1&<L
M$ & !GH/:K5 &7KL@:R%BJRO->DPQB)PAS@L3N/0  ]CZ8-5]&^T#4KQ;]W-
M_P"5&6 V^7Y>7VE<=\[@<\\#MBM6[L[>^A$5Q&'4$,.2"I'0@CD'W%-M+"VL
M0_V>,J9#EW9B[,?=B23^= '$^*"MSK4KVUS;B81B%=C1ABPW8#[CV;;QZ,3U
M%=;K,WDZ'/NO8K*:2,QQS.V LA'&.YY].:M7MG%?VKVTQ?RI.'",5W#N"1V/
M0TZ:UM[B 03P1RQ#&$=01QTZT <WX8%Z]Y--&81IQ41L@$P_>*6#%?,YZ@ ]
M.G>E\26&H723RR"W:TV&/RT0/(ZGL,QL03G'!Q6[8:7:Z8'6T5XXW);R_,8J
M"222 3QDGM5R@#.NKE+'1D+13994A2)6P^YL*J[L\')'.:S-(AN;75;:WU!Y
M!(EJZVJAE92@*!MQ !+#Y.HQR<=ZW[BWANX'@N(UDB<896&0:AM-,M+*5I88
MV\QAM,DDC2-CTRQ) ]J +=%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% %/5[62^T6^M(MOF3V\D2;C@992!G\Z\UTCP+XI:/2O[131[9M%TB:PM/)D
M>3[0\D80&7A<(,9P#G)->K44 >,:5\+=<M9;.:\M=+N!!JD5Z;<S979Y1215
M_=@#Y@K8Q@X'/&:W? G@'6?#?B>XU#4+U9T*2HTRS9-T7DWAG78#D#C+,V.@
MXKTJB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
>**** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ D$# 2(  A$! Q$!_\0
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MV@_[\G_XJC[1??\ /:#_ +\G_P"*I** %^T7W_/:#_OR?_BJ/M%]_P ]H/\
MOR?_ (JDHH 7[1??\]H/^_)_^*H^T7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[
M\G_XJC[1??\ /:#_ +\G_P"*I** %^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_
M (JDHH 7[1??\]H/^_)_^*H^T7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[\G_X
MJC[1??\ /:#_ +\G_P"*I** %^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_ (JD
MHH 7[1??\]H/^_)_^*H^T7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[\G_XJC[1
M??\ /:#_ +\G_P"*I** %^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_ (JDHH 7
M[1??\]H/^_)_^*H^T7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[\G_XJC[1??\
M/:#_ +\G_P"*I** %^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_ (JDHH 7[1??
M\]H/^_)_^*H^T7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[\G_XJC[1??\ /:#_
M +\G_P"*I** %^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_ (JDHH 7[1??\]H/
M^_)_^*H^T7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[\G_XJC[1??\ /:#_ +\G
M_P"*I** %^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_ (JDHH 7[1??\]H/^_)_
M^*H^T7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[\G_XJC[1??\ /:#_ +\G_P"*
MI** %^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_ (JDHH 7[1??\]H/^_)_^*H^
MT7W_ #V@_P"_)_\ BJ2B@!?M%]_SV@_[\G_XJC[1??\ /:#_ +\G_P"*I**
M%^T7W_/:#_OR?_BJ/M%]_P ]H/\ OR?_ (JDHH 7[1??\]H/^_)_^*I]M=7)
MO4AF>)D=&;Y8RI!!'N?6HZ(/^0I!_P!<I/YI0!JT444 %%%% !1110 5%<_\
M>DW^XW\JEJ*Y_P"/2;_<;^5 &/I__(,L_P#KA'_Z"*L57T__ )!EG_UPC_\
M015B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *(/\ D*0?
M]<I/YI11!_R%(/\ KE)_-* -6BBB@ HHHH @O'6.U=WN!;J,9E./E&??C-9T
MLU[_ &3%MNHUF>7'F.ZH2F3CG:1NP!V]:U9(HYHRDJ*Z'JK#(-1BSM@NT6\>
MW;LV[1C&<XQTZT 8BZE<DHZ3N2IC5(7VDS!B0QX )[X(P.*GM+N:6UNM\QN1
M]E27C;E68-E.,#C Z^M;'DQ;U?RTWH,*VT9 ]!44T4<5I.(XU0,K,=HQDXZT
M 8MA,_\ 9MI_H\I_<1]U_NCWJQYS_P#/M+^:_P"-,T__ )!EG_UPC_\ 015B
M@"+SG_Y]I?S7_&CSG_Y]I?S7_&I:* (O.?\ Y]I?S7_&CSG_ .?:7\U_QJ6B
M@"+SG_Y]I?S7_&CSG_Y]I?S7_&I:* (O.?\ Y]I?S7_&CSG_ .?:7\U_QJ6B
M@"+SG_Y]I?S7_&CSG_Y]I?S7_&I:* (O.?\ Y]I?S7_&CSG_ .?:7\U_QJ6B
M@"+SG_Y]I?S7_&CSG_Y]I?S7_&I:* (O.?\ Y]I?S7_&CSG_ .?:7\U_QJ6B
M@"+SG_Y]I?S7_&CSG_Y]I?S7_&I:* (O.?\ Y]I?S7_&CSG_ .?:7\U_QJ6B
M@"+SG_Y]I?S7_&CSG_Y]I?S7_&I:* (O.?\ Y]I?S7_&CSG_ .?:7\U_QJ6B
M@"+SG_Y]I?S7_&CSG_Y]I?S7_&I:* (O.?\ Y]I?S7_&CSG_ .?:7\U_QJ6B
M@"+SG_Y]I?S7_&CSG_Y]I?S7_&I:* (O.?\ Y]I?S7_&CSG_ .?:7\U_QJ6B
M@"+SG_Y]I?S7_&CSG_Y]I?S7_&I:* (O.?\ Y]I?S7_&CSG_ .?:7\U_QJ6B
M@"+SG_Y]I?S7_&CSG_Y]I?S7_&I:* (O.?\ Y]I?S7_&CSG_ .?:7\U_QJ6N
M5U#5[BS\9P0-/(;7"*8DZ98=QWYQ6=2HJ:3?>QG4J*"39TOG/_S[2_FO^-'G
M/_S[2_FO^-2T5H:$7G/_ ,^TOYK_ (T><_\ S[2_FO\ C4M% $7G/_S[2_FO
M^-'G/_S[2_FO^-2T4 1><_\ S[2_FO\ C1YS_P#/M+^:_P"-2T4 1><__/M+
M^:_XT><__/M+^:_XU+10!%YS_P#/M+^:_P"-'G/_ ,^TOYK_ (U+10!%YS_\
M^TOYK_C1YS_\^TOYK_C4M% $7G/_ ,^TOYK_ (T><_\ S[2_FO\ C4M% $7G
M/_S[2_FO^-'G/_S[2_FO^-2U@>+-2N-.T^$VLK12RR;=R@9P!S_2HJ34(N3Z
M$3FH1<F;7G/_ ,^TOYK_ (T><_\ S[2_FO\ C6)X2U2?4;"9+J4R30OC<1R5
M/3/ZUT%%.:G%274(34XJ2(O.?_GVE_-?\:/.?_GVE_-?\:EHJRR!K@HA=X)%
M4#)9BH _6LKP_K+:IXMN41R;2*!O*!4 @Y4$Y[T>+;Q;70I(\KON"(PI/)'<
MUC?#X%?$%P"""+8\'_>6N2I5?MHTU_6YRSJOVT8(]*HHHKK.H**** "BBB@
MJ*Y_X])O]QOY5+45S_QZ3?[C?RH Q]/_ .099_\ 7"/_ -!%6*KZ?_R#+/\
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M^/2;_<;^5 &/I_\ R#+/_KA'_P"@BK%5]/\ ^099_P#7"/\ ]!%6* "BBB@
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M]V'_ +Z/^%&;G^[#_P!]'_"I:* .6\:),VDPNZ)M6899"3C(/M7%00O/.D*
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MVGMQ@]JIZ_K<7_".(T0<-?QXC!'0=\GUKG_">H/::Q';F0K!<':R]BV/E/\
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M?_H(JQ5?3_\ D&6?_7"/_P!!%6* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BHYYX[:!YYG"11C<S'L*SI?$6F+:2S0W44SHA<1J<,W
MYU$IQCNR93C'=FK17-:%XK34)EM;Q!'<NQ"%!\A]!UZUTM*G4C47-$4*D9J\
M0HHHK0L**** "BBB@ HJ![RUCNA:O<1K.5W^66P<>M21RQS('BD61#T9#D?G
M2NF*Z'T444QA7)^-R[QV-O$S&21V'E@_>Z8_6NLKE=5(N_&^G6LH'EQ*''N>
M6_H*YL3K3Y>[2_$PQ&L.7O9'1V4!MK"W@)),<:J<]>!4]%%="5E8V2LK!111
M3&%%%% !1110!YYXPMDM]=9D!'G1B1LG.6Y!_E2W5Q)'X$LX5 V33N&/?@DB
MM3Q-8_VAXCL+;+()(6!<#.,9/]*Y.R$DE]:Q)EB9EVIG@G(KQ*MX5)6ZZ?D>
M14O&I*W73\C5U9WL_$%C.8U4+%;NHSP0 /\  TWQ();KQ-<Q(6DP0$7.<#:#
MQ71>-H83I0G\I/.\Y5\S'S8YXSZ5A^$=-^VZG]I,@5;5E8H5SO!R,>U74IOV
MCI+JTRJD'[3V2ZNY41[C5K/3-,RBXE=(G/;..M=!XBEBT_6]%N95 6($R%%Y
M(&*S]"TJ6/Q:Z,GEK:LTFU^>.BX/KR*O>.;9VBM+I59@A:-L#.,\C^1IQC)4
M93>Z:_ <8R5*4GOI^!:N_%%A=:-?-;O(D@38HD3&2V0,?K6+X3TFZDU."_,9
M2VBRP=APYQC _P ]JS9M$O8=1CL A>24*R$9"L",Y_#G]:]#TFTDL-)MK68@
MR1)M;:<C.3TK2DIUZB=1?#^9=-2K5+S7P_F<GXC\/&P2;58KDL3-N*%<%<GC
M!SSS6SK&M6W_  C(E9O,:\B,:^7TW8Y_ 5?URQ&H:/<09(8+O7']Y>17FD+,
MSQV\C,(FE4LA.,'H3['%*L_82:@M)+\?Z857[&345I)'H/A.".'P] Z ;I2S
MN?4YQ_(5MTR&"*VB6&!%2)!A54<4^O1IQY(*/8[H1Y8J/8****LL**** "CD
M].M% ."#0!Q/@ZQD&JW=RS*H@W0LO<DG_P"M7;5F:1I)TMKPF82_:9O-X7&W
MKQ^M:=88>G[.GRLQH0Y(6840?\A2#_KE)_-**(/^0I!_URD_FE;FQJT444 %
M>2>+A:ZWJUVXTE I A:YFT&YEG7;P2K@A2/3C%>MUY3XGM=,UO7IY+W4I])N
MR5AB34X)%B"C(8HP8(<\,.>N<@@X !ZG$ (4 Z;1VQ3Z;& L:@$$  9'>D>:
M*.+S7D18^N]F 'YT /J*Y_X])O\ <;^5"W,#E LT;&090!@=P]1ZTR:6.6TG
M,<BN%5E.TYP<=* ,K3_^099_]<(__015BJ^G_P#(,L_^N$?_ *"*L4 %%%%
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MO3_9'J!6O12]E'G]IU%[.//S]0HHHK4T"BBB@ KBO[,$WCZ1'B)B#^>=HXZ
M\Y]^OUKM:*RJTE4M?H[F52FIVOT84445J:A1110 4444 %%%% !1110 40?\
MA2#_ *Y2?S2BB#_D*0?]<I/YI0!JT444 %<+JMAX=:_E@\5>*/M3EMXL;F[6
M")%/*_NUQGCN<YKNJ\U\66AO/%%Y#:6NJ7&^&(7JP1VQ4KSM"/*0RG&>5_G0
M!Z!$]GJ>GJUO+'<6DJ_*\3Y5A[$&LUK-O[&L;&2WG:2".-F6%E7!48P">#@]
MN*M:'I$6C6+P1.S"6>2=LJ%P7;. !P .E:5 '/?V=>.ZB2(>:YC83C;^Y"DY
M'KG'IQR:FM+2:&UNB8?LW^BI%T4[F4-E^#WR.O/%;=17/_'I-_N-_*@#"L(Y
MO[-M/](Q^XC_ .68_NBK'ES?\_/_ )#%,T__ )!EG_UPC_\ 015B@"+RYO\
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M_P _/_D,4>7-_P _/_D,5+10!%Y<W_/S_P"0Q1Y<W_/S_P"0Q4M% $7ES?\
M/S_Y#%'ES?\ /S_Y#%2T4 1>7-_S\_\ D,4>7-_S\_\ D,5+10!%Y<W_ #\_
M^0Q1Y<W_ #\_^0Q4M% $7ES?\_/_ )#%'ES?\_/_ )#%2T4 1>7-_P _/_D,
M4ZT61=5AWR[_ -U)CY0,<K3Z(/\ D*0?]<I/YI0!JT444 %>1^,8+)=<N7U&
MYL9[J-4$F[11,^TAFSGS!D*@R?3CN<5ZY7G7B]=1'B61[?1XYBT"1PG^S/M
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M,W[:#]FU>>72M+&KQZDT<6FO++Y\R;\'@-RS9+ @8P:]FJ(VMNUP+@P1&8#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 449'J*,CU% !11D>HHR/44 %%&1ZBC(]10 449'J*,CU% !11D>HHR/44
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M&_E0!A6%M =-M"8(L^1'_ /[HJQ]EM_^>$7_ 'P*9I__ "#+/_KA'_Z"*L4
M1?9;?_GA%_WP*/LMO_SPB_[X%2T4 1?9;?\ YX1?]\"C[+;_ //"+_O@5+10
M!%]EM_\ GA%_WP*/LMO_ ,\(O^^!4M% $7V6W_YX1?\ ? H^RV__ #PB_P"^
M!4M% $7V6W_YX1?]\"C[+;_\\(O^^!4M% $7V6W_ .>$7_? H^RV_P#SPB_[
MX%2T4 1?9;?_ )X1?]\"C[+;_P#/"+_O@5+10!%]EM_^>$7_ 'P*/LMO_P \
M(O\ O@5+10!%]EM_^>$7_? H^RV__/"+_O@5+10!%]EM_P#GA%_WP*/LMO\
M\\(O^^!4M% $7V6W_P">$7_? H^RV_\ SPB_[X%2T4 1?9;?_GA%_P!\"C[+
M;_\ /"+_ +X%2T4 1?9;?_GA%_WP*/LMO_SPB_[X%2T4 1?9;?\ YX1?]\"C
M[+;_ //"+_O@5+10!%]EM_\ GA%_WP*/LMO_ ,\(O^^!4M% $7V6W_YX1?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM_:-C_S_ %K_ -_E_P :/[1L?^?ZU_[_ "_XT 6:*K?VC8_\_P!:_P#?Y?\
M&C^T;'_G^M?^_P O^- %FBJW]HV/_/\ 6O\ W^7_ !H_M&Q_Y_K7_O\ +_C0
M!9HJM_:-C_S_ %K_ -_E_P :/[1L?^?ZU_[_ "_XT 6:*K?VC8_\_P!:_P#?
MY?\ &C^T;'_G^M?^_P O^- %FBJW]HV/_/\ 6O\ W^7_ !H_M&Q_Y_K7_O\
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MT 6:*K?VC8_\_P!:_P#?Y?\ &C^T;'_G^M?^_P O^- %FBJW]HV/_/\ 6O\
MW^7_ !H_M&Q_Y_K7_O\ +_C0!9HJM_:-C_S_ %K_ -_E_P :/[1L?^?ZU_[_
M "_XT 6:*K?VC8_\_P!:_P#?Y?\ &C^T;'_G^M?^_P O^- %FBJW]HV/_/\
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M<VJB*2Z;A@5PN\^^1FI;C1=/NIGEF@):3'F!9&59,<?,H(#<<<@U>50JA5
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MN6(&/O$ GZXK2HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ D$# 2(  A$! Q$!_\0
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M^A_\<H^W:E_=3_OT/_CE2T4 1?;M2_NI_P!^A_\ '*/MVI?W4_[]#_XY4M%
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M&WM@]?X>1UH 73_^099_]<(__015BJ5A]I_LVTP8,>1'_"W]T>]6/])]8/\
MOEO\: ):*B_TGU@_[Y;_ !H_TGU@_P"^6_QH EHJ+_2?6#_OEO\ &C_2?6#_
M +Y;_&@"6BHO])]8/^^6_P :/])]8/\ OEO\: ):*B_TGU@_[Y;_ !H_TGU@
M_P"^6_QH EHJ+_2?6#_OEO\ &C_2?6#_ +Y;_&@"6BHO])]8/^^6_P :/])]
M8/\ OEO\: ):*B_TGU@_[Y;_ !H_TGU@_P"^6_QH EHJ+_2?6#_OEO\ &C_2
M?6#_ +Y;_&@"6BHO])]8/^^6_P :/])]8/\ OEO\: ):*B_TGU@_[Y;_ !H_
MTGU@_P"^6_QH EHJ+_2?6#_OEO\ &C_2?6#_ +Y;_&@"6BHO])]8/^^6_P :
M/])]8/\ OEO\: ):*B_TGU@_[Y;_ !H_TGU@_P"^6_QH EHJ+_2?6#_OEO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7<5Q8)6I?,Y,(K4PH@_Y"D'_ %RD_FE%$'_(4@_ZY2?S2NTZS5HHHH ****
M*U];?:K5HO+ADY#!)AE3@YYJG]AND@@C3RR\#F9"S'8"21L]< -P?8<5JT4
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M^_-_W];_ !H^SK_?F_[^M_C4M% $7V=?[\W_ '];_&C[.O\ ?F_[^M_C4M%
M$7V=?[\W_?UO\:/LZ_WYO^_K?XU+10!%]G7^_-_W];_&C[.O]^;_ +^M_C4M
M% $7V=?[\W_?UO\ &C[.O]^;_OZW^-2T4 1?9U_OS?\ ?UO\:/LZ_P!^;_OZ
MW^-2T4 1?9U_OS?]_6_QH^SK_?F_[^M_C4M% $7V=?[\W_?UO\:/LZ_WYO\
MOZW^-2T4 1?9U_OS?]_6_P :/LZ_WYO^_K?XU+10!%]G7^_-_P!_6_QH^SK_
M 'YO^_K?XU+10!%]G7^_-_W];_&C[.O]^;_OZW^-2US&M^*Y-,U)K2WMXI=@
M&YF8]2.F!6=2I&FN:1$ZD::O(Z'[.G_/27_OZW^-+]G7^_-_W];_ !KS[2-3
MGE\5Q73%0UQ*0X).T!O2N_NKRVL8#/<S+%$#C<WKZ5G1KQJ1<MK&=*LJB;VL
M.^SK_?F_[^M_C1]G7^_-_P!_6_QJ165T5U(96&01W%+70;D7V=?[\W_?UO\
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M/M5O_P ]X_\ OH4W3_\ D&6?_7"/_P!!%6* (?M5O_SWC_[Z%'VJW_Y[Q_\
M?0J:B@"'[5;_ //>/_OH4?:K?_GO'_WT*FHH A^U6_\ SWC_ .^A1]JM_P#G
MO'_WT*FHH A^U6__ #WC_P"^A1]JM_\ GO'_ -]"IJ* (?M5O_SWC_[Z%'VJ
MW_Y[Q_\ ?0J:B@"'[5;_ //>/_OH4?:K?_GO'_WT*FHH A^U6_\ SWC_ .^A
M1]JM_P#GO'_WT*FHH A^U6__ #WC_P"^A1]JM_\ GO'_ -]"IJ* (?M5O_SW
MC_[Z%'VJW_Y[Q_\ ?0J:B@"'[5;_ //>/_OH4?:K?_GO'_WT*FHH A^U6_\
MSWC_ .^A1]JM_P#GO'_WT*FHH A^U6__ #WC_P"^A1]JM_\ GO'_ -]"IJ*
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MY=*TL:O'J31Q::\LOGS)OP> W+-DL"!C!KV:HC:V[7 N#!$9@,"0H-P_'K0
MOEI+;B.2)2A4 HPR/H:8UE;,-K01E-FS85&W;G.,=*DFD\J(N(WD(Z*@R35*
M76+>&P%VZNH,GE;&*JP?)!!)('!![]J +?V:#S$D\F/?&-J-M&5'H#VJ.2"&
M"SN!#$D8969MB@9..IQ4!U:%9$5XI5!V[W^4K&6^Z"03U]LCD4)?QWMK<!8Y
M8V$6\"0 ;E8'##!/!P?>@"EI_P#R#+/_ *X1_P#H(JQ5?3P?[,L^/^6$?_H(
MJQ@^E !11@^E&#Z4 %%&#Z48/I0 448/I1@^E !11@^E&#Z4 %%&#Z48/I0
M448/I1@^E !12X/I2$@'!(!]": "CIR2 .Y/:L;5O$EGI9\L?Z1<'I'&1P?]
MH]JY^6ZUGQ3-';1PM:VQ&7QNV$9ZD]_H*YYXB,7RK5]D83KQB^5:L;?^)Y9/
M$,3PS/'9P2;2%/$BYY)'?/:M_2?%%KJD\L1B-ML3>&D<8(S_ /JK)U?PP;/0
M8HK))+F=9@SD+EFR,< = *S-1\,7MM=QQ6D%Q-$Z*/,*_P 1ZYQT ]ZXN?$4
MY-M7[_,Y.:O3DV]3J-3\5V%@K+"PNIPVTHAP![YZ?E6'-KFM:].T6EQ20Q
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M3)[UI[V)>]H?F:>]B'O:/YGG.M:5<:+=/"CN+6<[8V+?? P?FQ[UT]UX60Z
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M]*,'TH **,'THP?2@ HHP?2C!]* "BC!]*,'TH **,'THP?2@ HHP?2C!]*
M"BC!]*,'TH **,'THP?2@ H@_P"0I!_URD_FE&#Z40?\A2#_ *Y2?S2@#5HH
MHH **** (;J.::V>."?R)#TDV[L?A5865R+>.%9XE\L9#B'JV?0D\8]\Y[U?
MHSQGM0!E+HB*503$PG:94*C+LIR#GL/;V%.33A;6=SYL@FS!Y0R@ "*#@>_4
M\UIU%<\VDW^XW\J ,&PM;<Z;:$PIGR(_X?\ 9%6/LEO_ ,\(_P#OFL[^V;#3
M=(LWN+A<F!-J)\S'Y1V%1/XNT=8U83R,3_"L9R/K6<JM.+LY(S=6"=FS6^R6
M_P#SPC_[YH^R6_\ SPC_ .^:PU\::42P9;A0#P?+SN_7BIH_%NCR.%\^122
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M*-H0C!6BB'[);_\ /"/_ +YH^R6__/"/_OFIJ*LLA^R6_P#SPC_[YH^R6_\
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M% $/V2W_ .>$?_?-'V2W_P">$?\ WS4U% $/V2W_ .>$?_?-'V2W_P">$?\
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ML_XT;;C_ )Z1?]^S_C4M% $6VX_YZ1?]^S_C1MN/^>D7_?L_XU+10!%MN/\
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M-_C1]EB_V_\ OXW^- $U%0_98O\ ;_[^-_C1]EB_V_\ OXW^- $U%0_98O\
M;_[^-_C1]EB_V_\ OXW^- $U%0_98O\ ;_[^-_C1]EB_V_\ OXW^- $U%0_9
M8O\ ;_[^-_C1]EB_V_\ OXW^- $U%0_98O\ ;_[^-_C1]EB_V_\ OXW^- $U
M%0_98O\ ;_[^-_C1]EB_V_\ OXW^- $U%0_98O\ ;_[^-_C1]EB_V_\ OXW^
M- $U%0_98O\ ;_[^-_C1]EB_V_\ OXW^- $U%0_98O\ ;_[^-_C1]EB_V_\
MOXW^- $U%0_98O\ ;_[^-_C1]EB_V_\ OXW^- $U%0_98O\ ;_[^-_C1]EB_
MV_\ OXW^- $U%0_98O\ ;_[^-_C1]EB_V_\ OXW^- $U%0_98O\ ;_[^-_C1
M]EB_V_\ OXW^- $U%0_98O\ ;_[^-_C1]EB_V_\ OXW^- $U%0_98O\ ;_[^
M-_C1]EB_V_\ OXW^- $U%0_98O\ ;_[^-_C1]EB_V_\ OXW^- $U%0_98O\
M;_[^-_C1]EB_V_\ OXW^- $U%0_98O\ ;_[^-_C1]EB_V_\ OXW^- $U%0_9
M8O\ ;_[^-_C1]EB_V_\ OXW^- $U%0_98O\ ;_[^-_C1]EB_V_\ OXW^- $U
M%0_98O\ ;_[^-_C1]EB_V_\ OXW^- $U%0_98O\ ;_[^-_C1]EB_V_\ OXW^
M- $U%0_98O\ ;_[^-_C1]EB_V_\ OXW^- $U%0_98O\ ;_[^-_C1]EB_V_\
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MHS<_W8?^^C_A0!+146;G^[#_ -]'_"C-S_=A_P"^C_A0!+146;G^[#_WT?\
M"C-S_=A_[Z/^% $M%19N?[L/_?1_PHS<_P!V'_OH_P"% $M%19N?[L/_ 'T?
M\*,W/]V'_OH_X4 2T5%FY_NP_P#?1_PHS<_W8?\ OH_X4 2T5%FY_NP_]]'_
M  HS<_W8?^^C_A0!+146;G^[#_WT?\*,W/\ =A_[Z/\ A0!+146;G^[#_P!]
M'_"C-S_=A_[Z/^% $M%19N?[L/\ WT?\*,W/]V'_ +Z/^% $M%19N?[L/_?1
M_P *,W/]V'_OH_X4 2T5%FY_NP_]]'_"C-S_ '8?^^C_ (4 2T5%FY_NP_\
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MM?\ O\O^- %FBJW]HV'_ #_6O_?Y?\:/[1L?^?ZU_P"_R_XT 6:*K?VC8?\
M/]:_]_E_QH_M&P_Y_K7_ +_+_C0!9HJM_:-C_P _UK_W^7_&C^T;#_G^M?\
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M NV2Y/.,8&XU-=:18WDS330MYC*%<I(R;QZ-M(W#ZYJY'&D4:QQHJ(@"JJC
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MAC;S&&TR22-(V/3+$D#VH MT444 %%%% !1110 4444 %%%% !1110 4444
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E110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
